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MAGNETO-ELECTRIC NANOPARTICLES COBALT FERRITE (CoFe2O4) – 
BARIUM TITANATE (BaTiO3) FOR NON-INVASIVE NEURAL MODULATIONS 
Non-invasive brain stimulation is valuable for studying neural circuits and 
treating various neurological disorders in human. However, current technologies of non-
invasive brain stimulation usually have low spatial and temporal precision and poor brain 
penetration, which greatly limit their application. A new class of nanoparticles known as 
magneto-electric nanoparticles (MENs) is highly efficient in coupling an externally 
applied magnetics wave with generating local electric fields for neuronal activity 
modulation. Here, a new type of MENs was developed that consisted of CoFe2O4-
BaTiO3 and had excellent magneto-electrical coupling properties. Calcium imaging 
technique was used to demonstrate their efficacy in evoking neuronal activity in 
organotyic and acute cortical slices that expressed GCaMP6 protein. For in vivo non-
invasive delivery of MENs to brain, fluorescently labeled MENs were intravenously 
injected and attracted to pass through blood brain barrier to a targeted brain region by 
applying a focal magnet field. Magnetic wave (~450 G at 10 Hz) applied to mouse brain 
was able to activate cortical network activity, as revealed by in vivo two-photon and 
mesoscopic imaging of calcium signals at both cellular and global network levels. The 
effect was further confirmed by the increased number of c-Fos expressing cells after 
magnetic stimulation. Histological analysis indicated that neither brain delivery of MENs 
nor the subsequent magnetic stimulation caused any significant increases in the numbers 
of GFAP and IBA1 positive astrocytes and microglia in the brain. MENs stimulation also 
show high efficacy in short-term pain relieve when tested with a tibial nerve injury mouse 
 x 
model. The study demonstrates the feasibility of using MENs as a novel efficient and 
non-invasive technique of brain stimulation, which may have great potential for 
translation.  
 
Fletcher White, Ph.D., co-Chair 
Armin Blesch, Ph.D., co-Chair 
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Chapter 1 Introduction 
Non-invasive neural stimulation, a paradigm shift in understanding, diagnosing, 
and treating neurological diseases 
 For more than a century, neuroscientific research has raced to understand the 
mechanism and to find treatment approach behind the manifestation of neurological 
related diseases. Routinely, investigators are limited to observe the changes of disease 
progression through behavior or record and interpret correlates of brain activity. For 
many decades, the same principle is usually followed by giving a diseased brain a 
specific task, recording its activity, analyzing its activity and compare to a normal healthy 
brain. We can then develop a theory of how the changes in a diseased brain activity 
compare to a normal brain, thus implicating the disease’s effects. In the context of a more 
global study, pharmacological applications were used to block or enhance the neural 
network and observe their functional outcome. However, for more in depth understanding 
of which specific part of a neural pathway is affected by certain disease, investigators had 
to manipulate the cause and observed the predicted effect, in order to develop 
correlational evidence. In order to do so, historically, investigators usually relied upon 
interfering with the activity of the interest region via targeted pharmacological treatment 
or lesioning. The co-occurrence of a loss of function with inhibiting the activity (targeted 
pharmacological treatment) or interfering the signaling pathways (a lesion) of a specific 
part of neural region can be then interpreted as a causal relationship. This paradigm of 
investigation works well in certain animal disease models but not feasible in human 
studies4. 
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 In the example of neuropathic pain, which is defined as pain occurring in an area 
of body affected by neurological diseases or injury that results in central and peripheral 
sensitization. Historically, therapeutic approaches to neuropathic pain have focused on 
reducing or blocking neuronal activity within the pain pathway. Currently clinical 
approach includes pharmacological treatments with various receptors inhibitors (Voltage-
gated Calcium channels inhibitors, serotonin and norepinephrine reuptake inhibitor) to 
more popular but riskier opioid-based analgesics (codeine, fentanyl, tramadol, morphine, 
etc...)5. A central issue with drug treatments for pain involves dangerous side effects, 
non-regional specific targeting (receptor inhibitors), and more importantly chronic 
sensitization to the substance (addiction) that are often fatal. Surgical techniques have 
also been attempted to interfere with pain pathway via lesioning regions of brain or 
neural tracts in spinal cord6. Surgical intervention via lesioning produced highly 
contradictory outcomes among different studies of pain management6. The reasons are 
followed: 
First, it is extremely difficult to treat the mechanistic manifestations of refractory 
neurological diseases such as epilepsy, pain, various type of traumatic brain injuries 
because the injured nervous system (brains, spinal cord), on top of the effects caused by 
the disease itself, may have developed individual strategies to compensate for the defect4. 
Second, studies done by interfering with the neural circuitry via lesioning presents an 
extremely invasive approach in studying disease in human patients. Even with approval, 
the number of patients (and their health background) in a study are often small and 
inhomogeneous with respect to their individual anatomy and lesion, thus interpretations 
about the disease relevance of the lesion and treatment efficacy must be taken with a 
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grain of salt4. Third, lesioning is usually the last resort in both diagnostic and treatment 
approach for neurological disease. 
 A solution to this problem came with the invention of non-invasive brain 
stimulation (NIBS) techniques. The idea of stimulating neuronal activity wirelessly by 
external forces has only been applied as a treatment approach towards some diseases in 
human within the past 30 years and as a tool for research in neuroscience only relatively 
recently7, 8. The most established techniques are Transcranial Magnetic Stimulation 
(TMS) and Transcranial Electrical Stimulation (TES), which also are the only FDA-
approved non-invasive stimulation techniques used in the clinics. These techniques 
utilize strong external magnetic field (TMS) or electric field (TES) applied for short 
duration to elicit action potentials thus enhancing neuronal activity8, 9, 10. With full 
manipulation of the applied force parameters (i.e. strength, duration, frequency), 
investigators can either functionally inhibit a certain brain area or excite a structure and 
measures the outcome. All of this can be done harmlessly while the subject is fully 
awake, thus provide incredible tools for human applications. 
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Non-invasive brain stimulations, powerful approaches that are not without their 
flaws 
 For a non-invasive brain stimulation technique to be fully effective, four criteria 
have to be met: spatial resolution, temporal resolution, non-invasiveness, and clinically 
feasibility. Spatial resolution is defined as how small (or specific) an area is being 
stimulated. As the treatment is applied, if it only stimulates a specific region of the brain 
or even a subpopulation of neurons, it is said to have a high spatial resolution. Temporal 
resolution is defined as the delay period between treatment is applied and the effects 
observed. If the effects observed immediately after treatment application, it is said to 
have high temporal resolution8. Figure 1 (adapted from Polania et al. 2018) shows 
eloquently diverse types of non-invasive brain stimulation techniques (both clinical and 
research) with their corresponding spatial and temporal resolution effects and their 
increasing adaptation in scientific studies. These effects determine the technique’s level 
of efficacy. In combination with its non-invasiveness mode of treatment and clinical 
feasibility, these are four primary determinants for the transition of the technique from 
research to clinical. Furthermore, other important factors should also be considered for 
this transition ranges from the toxicity, off target side effects, to accessibilities and cost.   
The two most commonly used forms of noninvasive brain stimulation clinically are 
Transcranial Magnetic Stimulation (TMS) and transcranial Direct & Alternating Current 
Stimulation (tDCS & tACS)11, 12, 13. However, they have relatively low spatial and 
temporal precisions, which greatly diminish their efficacy and result interpretation. For 
example, regular TMS require high intensity of external field applied (~20k-50k Gauss, 
G, or about 2-5 Tesla, T,) but have a spatial resolution of 3-5 cm and depth of penetration 
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of ~1-1.5 cm, which allows for stimulating cortical gyrus14, 15. tDCS also has very low 
spatial resolution and it is used to target larger superficial cortical area but has limited 
effects on deep brain areas14, 16, 17. In the example of neuropathic pain, TMS has been 
used in clinical trials for pain management but produces unreliable results. A meta-
analysis study of 23 clinical trials that use TMS in patients who suffered from long term 
pains reported only 5 out of 23 trials yield more than 50% of patients reported pain 
relieve18. Among these five effective trials, all patients who reported to experience less 
pain only do so partially and in very short-term. The treatment had to be applied at high 
frequency and high magnetic intensity to consistently achieve lower pain threshold.  
For the past 15 years, recent approaches like optogenetics19, 20 have improved in ways 
that were limited in tDCS and TMS (i.e. cellular specificity and temporal resolution). 
Optogenetics utilize light to stimulate with extremely high spatial and temporal 
resolutions (i.e. a subpopulation of neurons in millisecond timescale) by taking advantage 
of the light-sensitive proteins introduced to the subject. This technique, however, presents 
huge drawbacks of required genetic modifications in the subject. Very recently, acoustic-
based transcranial stimulations such as High Intensity Focused Ultrasound (HIFU) and 
Transcranial Doppler Sonography (TCDS) were used to study TBI13, 21, Parkinson 
disease22, tremor23, and neuropathic pain22 with improved spatial resolution and 
penetration. Investigators also tried to use focused ultrasound in low intensities for brain 
stimulation24 with Legon’s group done tests on human subjects25. Although the 
stimulation size of 4.9 mm in depth and 18 mm in diameter shown to be effective in 
evoking neuronal activity, high volume release of thermal energy due to continuous 
oscillating sound waves could decrease synaptic transmission, and results in tissue 
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homogenization, protein denaturation, and DNA fragmentation. This remains a critical 
hurdle of HIFU research to pass in optimizing its safety and efficacy26, 27. 
 
Figure 1. Overview of non-invasive brain stimulation approaches (adapted from Polania et al. 
2018). A. The temporal and spatial resolution at which different causal brain interventions work. 
Non-invasive brain stimulation methods work at the mesoscale level, and the temporal resolution 
varies between high and low depending on the specific stimulation protocol. Non-invasive brain 
stimulation necessarily involves the relatively indiscriminate activation of large numbers of neurons; 
the apparent temporal and spatial specificity seen in studies is thus unlikely to reflect the anatomical 
and temporal specificity of the stimulation. Instead, it may indicate disruption of behaviorally 
relevant operations that are carried out by a relatively small number of cell groups within larger brain 
regions. B. The exponentially growing number of citations per year for TMS, tDCS and tACS.  
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Magnetic-electric nanoparticles-based materials, a potentially promising new 
vehicle for neural stimulation 
 In the last decade, nanoscale neural interfaces have become a valuable tool for 
drug delivery, monitoring and modulating neuronal activity28. Developments such as state 
of the art nanoelectrodes was used to localize epileptic foci in mice29, while various types 
of nanoparticles were used in drug delivery3, 30 or neuronal activity modulations31, 32.  
Within this new realm of nanoparticle-based neural modulation, diverse types of 
nanoparticles with diverse properties have been shown, at least in research stage, to have 
the abilities to efficiently stimulate neurons. Two ways of nanomaterials that have been 
shown to be very effectively stimulate neuronal activity are through increase in surface 
temperature31, 32 or induce local magnetic field33. Magneto-thermal brain stimulation 
takes advantage of magnetic nanoparticles that generate heat when an external magnetic 
field is apply. While magnetic ferroelectric nanoparticles can generate its own micro 
magnetic field in response to external applied field to activate neurons in vitro. These 
approaches, however, face moderate problems of toxicity and off target effects. In the 
case of magneto-thermal nanoparticles, introduction of nanoparticles to the animal 
requires an invasive step direct delivery of particles into the brain. While magnetic 
ferroelectric nanoparticles stimulation required application of a very high intensity of 
external field (~8-15k G), very close to the strength require for TMS, thus present a 
possibility of off-target activation. Despite these drawbacks, nanoparticle-based 
technique presents a tremendous potential of being the next frontier for neural modulation 
due to its limitless manipulation of the particles and the stimulation modes to obtain 
desired effects.  
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My dissertation will focus on a type of magnetic nanoparticles called magneto-
electric nanoparticles (MENs) as a novel and more effective mode of neuronal 
stimulation. The concept of MENs was first proposed by Guduru et al. as a way to 
delivery drug to a target area by taking advantage of the magnetic-electric coupling 
between the particles and the drug of interest3. MENs composed of a core-shell cobalt 
ferrite (CoFe2O4) – barium titanate (BaTiO3) structure size ranges between 25 ~ 35 
nanometers (nm), in which cobalt ferrite (CoFe2O4) cubic core is tightly enveloped by 
spherical barium titanate (BaTiO3) shell (Figure 2A-B). The ferrite core is the only FDA-
approved magnetic nanoparticle that has been used as an active ingredient in radioactive 
dyes for functional magnetic resonance imaging (MRI)34, although the core compound 
itself is non-radioactive. Depending on the type of external magnetic field is applied, the 
CoFe2O4 generates different physical properties. When a moderately strong external field 
is applied (~3-6k G or 0.3-0.6 T), the core becomes ferromagnetic and becomes attracted 
towards the field. However, when a weak field is applied at a particular frequency (~300-
600 G or 0.03-0.06 T), the core vibrates (micro-vibration) in space and its cobalt-iron 
oxide bonding becomes stretch out ever so slightly. The physical stretching of the core 
induces mechanical stress on the barium titanate (BaTiO3) piezoelectric perovskite shell. 
Because of its nature as a piezoelectric perovskite shell, any mechanical stress will induce 
surface charge separation (in this case, charge redistribution) that allow each individual 
shell to generate its own micro local electric field (on the order of 1000V/m or higher)35. 
This precise core-shell magnetic-electric couplings of these MENs enable Nair et al. 
group to bind antiretroviral HIV drug via electrostatic interaction, localize the drug-
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carrying MENs to the targeted site and release them, all done wirelessly via controlling 





These MENs provide many advantages over other nanoparticle-based stimulation 
approach: first, its relatively small size allows easy traverse across the blood brain barrier 
(BBB).  Second, its ferromagtically attractiveness towards moderately strong magnetic 
field allow precise localization of particles to a region of interest. Third, the sub-threshold 
low intensity magnetic field required for both localization and stimulation ensure no off-
target activation. Fourth, most importantly, the magnetic-electric coupling increase 
efficiency and latency period of stimulation, which allow effective enhancement of 
neuronal activity. And fifth, because these particles have been used for drug delivery, 
modification of MENs by attachment of antibodies can potentially improve its specificity 
and enhance its stimulatory efficacy. The unique properties of MENs, due to their small 
size and the ME effect not displayed by any other nanoparticles known to date, may 
provide significant improvements over currently used techniques in in efficacy, precision, 
and tissue penetration for noninvasive brain stimulation. However, to date, no direct 
effect of MENs on stimulating individual neurons in a focal brain region and/or a large 
neural network has been demonstrated.
Figure 2. Cobalt ferrite (CoFe2O4) – barium titanate (BaTiO3), MENs composed of 
core-shell structure. A. MENs are synthesized via coordination chemistry in which cobalt 
ferrite (CoFe2O4) is made from the reaction of Cobalt-2-nitrate-hexahydrate with Iron-2-
nitrate nonahydrate and barium titanate (BaTiO3) is made from reaction of barium 
carbonate with titanium isoporoxide1. The combination reaction of cobalt ferrite (CoFe2O4) 
and barium titanate (BaTiO3) generates the MENs1, 2, 3. B. Electron microscopic images of 
core-shell MENs (adapted from Nair et al. 2013)3 
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Overview of dissertation chapters 
 The central questions in this dissertation is: Do magneto-electric nanoparticles 
(MENs) cobalt ferrite (CoFe2O4) – barium titanate (BaTiO3) stimulation enhance 
neuronal activity (specifically cortical neurons) both in vitro and in vivo? If so, what is 
the spatial and temporal profile of the stimulatory effects? And what type of effects do 
MENs stimulation have, in the context of therapeutic approach, on refractory disease 
animal models, specifically neuropathic pain?  
 The first question of does MENs stimulation enhance neuronal activity can be 
broken down into several critical components that need to be validated: (i) Can MENs 
magnetic and electric effects be measured prior to biological testing? (ii) What effects 
does MENs stimulation have on cortical neuronal activity in vitro? (iii) Can MENs be 
direct through BBB and localized in the brain in vivo? And (iv) What effects does MENs 
stimulation have on neuronal activity in vivo? 
 In Chapter 2, I address the question of how to measure MENs magnetic and 
electric effects before testing on neurons by describe how MENs are prepared and the 
evaluations of their magnetic and electric properties in an aqueous solution. I then tested 
their effects on a cortical neuronal culture in vitro and test how different types of the 
applied external magnetic fields induce different neuronal responses. Chapter 3 moves on 
to determine whether MENs can be drawn through BBB after treatment and localized in a 
brain region in vivo by assessing MENs spatial and temporal profile both in the blood 
stream and brain motor cortex. In the same chapter, I also examine particle toxicity by 
assessing whether the presence of MENs in the brain causes any short-term neural 
inflammation. Chapter 4 describes the effects of MENs stimulation on neuronal activity 
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in vivo validated via various imaging techniques and characterizes both the temporal and 
spatial profile of the effects. Finally, Chapter 5 examines the effects of MENs stimulation 
on a neuropathic pain animal model of tibial nerve transection injury. Hypothesis on the 
delivery and targeting of MENs to the brain in a live biological system, its stimulatory 
effects on neuronal activity (i.e. brain function), and its promising application as a 
therapeutic approach to neuropathic pain are formulated based on the above results in the 
Chapter 6 of this dissertation. Also, in this last Chapter, I report more recent efforts in 
improve the specificity of the MENs targeting and its effects efficacy by conjugating 
particles with various antibodies.
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Chapter 2 - MENs exhibit unique magnetic-electric coupling, in response to external 
magnetic field, which enhances cortical neuronal activity in vitro 
Introduction 
 To test the effects of MENs stimulation on neurons, I first focused on how to 
make MENs biocompatible and test its magnetic and electric properties. As noted in last 
chapter, MENs were fabricated by our collaborators Khizroev group at University of 
Miami2 via hydrothermal method, i.e. in a high-pressure chamber at high-temperature for 
extended period of time to induce product crystallization. This core-shell structure 
particle ranges between 25 nm to 30 nm in size. MENs are multiferroics (exhibit both 
magnetic and electric polarizations) that consist of a magnetostrictive core and 
piezoelectric perovskite shell36. The magnetostrictive core responds to the applied 
external magnetic field by contracting and expanding (for weak applied field <2000 G) 
and becomes ferromagnetic (for stronger applied field above 3000 G)37. The contracting 
and expanding core put a physical strain (i.e. mechanical stress) on the piezoelectric shell 
constituent, which induce electrical polarization of the shell. This electrical polarization 
manifests through surface charge redistribution of the outer shell that in turn generates an 






Due to its nature as core-shell magnetic nanoparticle, aggregations (or 
agglomerations) are common occurrence in any aqueous suspension. To understand core-
shell particle agglomerations, one needs to understand the physics of how agglomerations 
occurs. In brief, for core-shell complex such as (CoFe2O4) – (BaTiO3), the particle 
surface that interact with surrounding liquid, i.e. the surface of the BaTiO3 shell, is called 
the Stern Layer. The ions of the outer shell continuously interact with ionic charges of 
the surrounding liquid (i.e. water) solution. As particle continue to interact with ions from 
the surrounding solution, this creates an interface between the outer shell and the 
surrounding water called the diffuse layer. So, the electrical potential between the Stern 
Layer and the diffuse layer is called the zeta (ζ) potential38. The higher zeta potential, the 
more stable the dispersion, the better the particles will repel each other. The lower the 
zeta potential, the less stable the dispersion, particles will tend to agglomerate. 
Figure 3. MENs produce different properties depends on the type of the applied 
external magnetic field. A. Application of a strong permanent external magnetic 
field can draw and localize MENs towards the field source. B. Weaker oscillating 
magnetic field at specific frequency ranges can induce core-shell’s magnetic-electric 
coupling property that resulted in generation of electric field.   
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Agglomeration of particles has detrimental effects to living cells and tissues34. To prevent 
MENs agglomerations, particles are coated with a biocompatible, low viscosity 
monoglycerides that increase particles zeta potential while maintain the integrity of the 
magneto-electric properties. Its magnetic and electric properties were tested in a polar 
aqueous solution.  
Magnetic fields are ideal for noninvasive manipulations of neural activity as they 
can achieve deep tissue penetration and localization by tuning force-inducing field 
gradients. To overcome the weak interaction between sub-threshold magnetic field and 
biological molecules, magnetic fields should be translated into other forces. Previous 
efforts were made in developing magnetic-based nanoparticles that translate external 
magnetic field into other forces for neuronal stimulation31, 33. In vitro experiments done 
by Tay et al. with silicone-coated Nickle-Iron (NiFe) particles and Chen et al. with Iron-
Oxide-Oleate (Fe3(C18H33O2)8 showed that by applying an external magnetic field and 
taking advantage of the enhanced magnetic coupling33 and magnetic-thermal coupling31, 
they were able to stimulate neuronal activities. Their techniques encountered several 
drawbacks including demagnetization of the particles33 and over-heating of particles 
causes cellular dysfunction if external field is applied for long period of time31. Derived 
from similar concept, these MENs take advantage of the magnetic-electric coupling to 
produce its effects. Our aim is to activate MENs in an in vitro setting and with different 




MENs functionalization with Glycerol Monooleate (GMO). MENs were 
synthesized using the hydrothermal method as described in Guduru et al.39. It composes 
of an-almost perfect lattice matched surface interface between the magnetostrictive core 
and the piezoelectric shell (Figure 3 & Figure 4). To eliminate aggregation and potential 
toxicity, MENs were surface functionalized by a 2-nm thick coating of glycerol 
monooleate (GMO) as followed: MENs were washed twice with phosphate-buffered 
saline, PBS (pH – 7.4) and sonicated for 2 mins between washes for uniform dispersion 
in solution. MENs were then suspended in glycerol mono-oleate (GMO) solution (8 µL 
GMO/1 g MENs) and mixed thoroughly on a rotator for 12 hours. Excess GMO were 
then removed by extraction with 1 ml of 70% ethanol:phosphate-buffered saline (PBS) 
and two subsequent washes with PBS. Finally, the MENs-GMO mixture were suspended 
in saline and store at -20 oC (for short-term storage of 3-5 days) or freeze dried in liquid 
nitrogen for long term storage (more than 1 week). To prepare CoFe2O4-BaTiO3 -Texas 
Red, fluorescent MENs (fMENs), Texas Red NHS ester was first reacted with oleylamine 
(2:1 molar ratio) for 18-24 hours on a rotator in a dark environment. Hexane was added 
to help dissolved the oleylamine-Texas Red mixture. The solution of oleylamine-Texas 
Red NHS ester was then combined with the GMO-MENs mixture (1:3 volume ratio of 
GMO-MENs: oleyamine-TexasRed). This mixture was then rotated for 12 hours to allow 
coating. After removal of excess GMO through multiple washes in PBS, the final product 
was store at -20 oC (short-term storage). 
Assessment of MENs ferromagnetic properties. 2 µL of fMENs (of 
concentration 5 mg/ml Saline) were mixed with 0.1% Agarose solution on a 10mm cell 
 16 
culture dish. The solution was then sonicated with Branson 1510 sonicator (NIST, 
Gaithersburg, MD) for 30 seconds to ensure uniform distribution of fMENs in Agarose. 
A 3500 G neodymium (Nd) conical shape permanent magnet was then placed with the tip 
at the center of the culture dish for 15 minutes. Images where taken both before magnetic 
application and after magnetic application with a 5x objective using an Olympus IX71 
(Olympus America, Merryville, NY) inverted microscope. 
Assessment of MENs electric properties. A mixture of 3 µl of 10 mM di-8-
ANEPPs (di-8-butyl-amino-naphthyl-ethylene-pyridinium-propyl-sulfonate; Sigma 
Aldrich) and 2.5 µl of 20% pluronic: DI water was combined with 1ml organically 
modified silicate (ormosil) in a 1.5 ml Eppendorf tube. This yielded a “loading solution” 
contains approximately 30 µM ANEPPs and 0.05% pluronic. 3 µl of MENs and 10 µl of 
ANEPP-ormosil dye solution was combine in a centrifuge tube and sonicated. A drop ~1-
2 µl of mixture was then place onto a microspic slide topped with cover slip. A 
continuous wave of ~450-600 Oe magnetic field was applied to the top of the dish during 
fluorescence imaging process. Dye signals was captured using a fluorescence microscope 
(Zeiss AxioVert 200, Zeiss, Germany) equipped with an oil immersion objective (20x), a 
monochromator and a cooled CCD camera. Applied excitation wavelength for ANEPPs 
was done at 485 nm with observed emissions at 595 nm and 700 nm. Images was 
obtained with MetaFluor 7.11. Two addition control groups were done with ANEPP-
ormosil and magnetic field (without MENs) and ANEPP-ormosil and MENs (without 






In vitro calcium imaging of cortical neurons in organotypic GCaMP6 brain 
slices. Cortical culture slice preparation: Brain tissue was obtained from 3-5 days old 
C57BL mice (n=5). The animals were quickly decapitated and the brain was removed and 
immediately immersed in an ice-cold cutting aCSF solution (2 mM KCl, 1 mM MgCl2, 2 
mM MgSO4, 1.25 mM NaH2PO4, 26 mM NaHCO3, 1 mM CaCl2, 10 mM D-Glucose, 
206 mM Sucrose). The cerebellum was then removed, and the brain was fixed onto the 
cutting stage with glue at the caudal end. Vibratome VT1200 (Leica Biosystems, Buffalo 
Grove, IL.) sectioning apparatus was used to section the brain into coronal slices of 350 
µm thick at a cutting velocity of 0.75 mm/minutes. The slices were then collected and 
stored in a cold oxygenated aCSF solution (126 mM NaCl, 2.5 mM KCl, 2 mM MgSO4, 
1.25 mM NaH2PO4, 26 mM NaHCO3, 2 mM CaCl2, 10 mM D-Glucose). Only intact 
slices were then arranged carefully onto semi-porous membranes (4 slices/membrane). 
Figure 4. Transmission electron microscopy (TEM) image of a MEN. The almost-
perfect lattice matched surface interface between the magnetostrictive core and the 
piezoelectric shell (shown with broken line) is vital for enabling MENs with record high 
ME values on the order of 5 V/cm/Oe in the frequency range, 0 to 200 Hz, under study.  
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The slices were cultivated at ~37 oC and 5% CO2 in a culturing medium consisting of 
46% Basal Medium Eagle (BME), 25% Earle’s Salt Solution, 25% fetal bovine solution 
(FBS), 3% of 22% Glucose solution, and 1% L-Glutamine-Penecilin-Streptomycin 
solution. This medium was micro-filtered every time prior to addition into slice culture. 
75% of medium were change every three days. Magnetic field application: Prior to 
imaging, a culture slice was taken from the culture well via cutting the membrane 
surround the slice then place in a custom-made recording chamber filled with 37 oC 
aCSF. The recording chamber is a 2-cm diameter well with glass bottom in which the 
whole chamber is position between two electromagnets for stimulation. 5 µL of MENs 
(at a concentration of 5 mg/mL aCSF) was added to the recording chamber. A 5000 G 
conical magnet was applied for ~15 minutes under the glass to draw MENs to a small 
area within the slice. For stimulation, the recording chamber with diameter of ~10 mm 
contains the cultures were place between two electromagnets. A sinusoidal magnetic field 
of ~450 G with 50 ms pulse width at 10 Hz frequency was applied to stimulate the MENs 
during the imaging process. Two-photon imaging: In vitro two-photon imaging was 
performed using a Prairie Technologies Ultima 4423 two-photon system (Bruker Inc., 
Middleton, WI) equipped with a MaiTai Ti:Sapphire laser (Newport, Mountain View, 
CA) tuned to 900 nm. Band-pass filtered fluorescence (560-600 nm) was collected by 
photomultiplier tubes of the system. The average laser power on the sample was ~20-30 
mW. All experiments were acquired at a resolution of 512 x 512 pixels using a 20x 
water-immersion objective (Nikon Instruments Inc., Melville, NY). Images were capture 
at a rate of 4-5 fps. Typically, each recording session consisted of 30 s of baseline 
recording, 40s with magnetic field application, and 30 s of post-magnetic application 
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period. 
Ex vivo calcium imaging of acute GCaMP6 cortical slices. Cortical slice 
preparation: Thy1-GCaMP6s transgenic mice, in which layers II/III and V pyramidal 
neurons express GCaMP6 calcium sensor protein, were purchased from Jackson’s 
Laboratory and bred locally. The mice (n=4) at the age of ---were anesthetized with 78 
mg/kg ketamine and 22 mg/kg xylazine (intraperitoneally) and decapitated. The brain 
was removed and immediately placed in an ice-cold oxygenated sucrose artificial 
cerebral spinal fluid (s-ACSF) solution (206 mM sucrose, 2 mM KCl, 1 mM MgCl2, 2 
mM MgSO4, 1.25 mM NaH2PO4, 26 mM NaHCO3, 10 mM D-glucose, 1 mM CaCl2). 
After 1-2 mins, the brain was situated on a cutting stage such that the cortices faced the 
approaching blade. Agarose gel was used as cushion against the ventral part of the brain 
to prevent movement while cutting. Slices of 350 µm thick were cut with a Vibratome 
(Leica VT1200S; Leica, Nusslock, Germany) when the brain was submerged in the 
cutting solution. The slices were then incubated at 37 oC for 1 hour in a gridded chamber 
filled with oxygenated ACSF (124 mM NaCl, 3 mM KCl, 2 mM MgSO4, 1.25 mM 
NaH2PO4, 26 mM NaHCO3, 10 mM D-glucose, 1 mM CaCl2). Each slice was on its 
own grid for up to 4 hours. Calcium imaging:  A custom-built recording chamber was 
made by attaching a temperature control heated well (Thermal Well Temperature 
Controller TC-100, BioScience Tools, San Diego, CA) onto a clear cover slip glass. A 
liquid inflow and a vacuum outflow tubing were installed to generate aCSF current 
through the chamber. A cortical slice was placed in the chamber and secured with a metal 
ring. Calcium activities of these slices were imaged with a system consisting of a Leica 
DM6000 FS upright microscope with a fluorescence light source directed through a 10x 
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water submerge objective (Leica, Nusslock, Germany). Images were capture with an 
iXON EMCCD DU-88U camera system (Andor USA, Concord, MA) at ~45-50 fps. 
Cortical slices were imaged at ~35 oC in ACSF with 20 µM bicuculline. MENs treatment 
and stimulation parameters: After the liquid flow of the recording chamber was turn off 
briefly, 20 µL of MENs (concentration of 5 mg/mL in aCSF) was added to the chamber. 
A 5000 G conical magnet was applied under the glass for ~5-8 mins to draw MENs to a 
small area within the slice. Liquid flow was turned back on prior to stimulation and 
recording. For stimulation, the recording chamber with diameter of ~10 mm containing 
the slice was placed between a pair of electromagnets.  A unipolar magnetic field of 750-
875 G with 200 ms pulse-width was applied to stimulate the MENs during the imaging 
process. 
Data analysis of Ca imaging. videos of calcium signals from cultured slices and 
in vitro imaging were analyzed post hoc using ImageJ software (NIH) with a Time Series 
Analyzer plugin (Balaji J. UCLA). For all calcium imaging videos, only active cells (cells 
that produce calcium fluorescence flashes throughout all frames) were analyzed. To 
analyze individual cells, three separate background points was chosen by drawing circles 
with the same diameter as the respective cell body in the surrounding area within the cell 
body vicinity. The background areas selected did not include dendrites and other visible 
neuronal structures. Data obtained includes cell body response and the three background 
fluorescent profiles. Fluorescence calcium signal of a cell ∆F/F was calculated by 
equation (1) excerpt from Chen et al. group 40 that was developed by Kerlin and his 
colleagues 41:  




	    and 𝐹-./0 = 𝐹1022 − 𝑟 ∗ 𝐹6     (Eq.1) 
 21 
where FB is the average baseline fluorescence over three different regions surrounding the 
analyzed cell of interest and r is the contamination ratio standard constant 0.7. These data 
were then used to construct a calcium peak profiles using OriginPro 9.1 (OriginLab, 
Northampton, MA). Analyses of peak amplitude, frequency, and durations were done 
with Peak analysis toolbox of OriginPro9.1. 
Statistics. Mean values and final plots were developed in Microsoft Excel, Jmp 
Analysis 11 (SAS Institute Inc. 2013. Cary, NC), and GraphPad Prism 6 (GraphPad 
Software, La Jolla, California). All statistical analyses were done with Jmp Analysis 11 
and GraphPad Prism 6. ANOVA analyses were used for comparing calcium amplitudes 
of the same group across different time points (Repeated measures Anova), amplitudes 
and frequencies of calcium imaging data (one-way). For comparisons that yield statistical 
significance, Tukey’s HSD post-hoc analyses were applied for further comparisons 




MENs could be localized with a strong applied magnetic field and produce 
electric field with a weaker applied field. To confirm the attraction property of MENs 
towards a strong external Nd magnetic field, a uniform mixture of 0.1% agarose with 5 
mg/ml fluorescent fMENs-Saline solution was prepared. This particular agarose 
concentration ensures the similarity in texture to brain tissue. We observed a uniform 
distribution of MENs throughout the mixture (Figure 5-top) prior to magnet application. 
An external Nd magnet of ~4500 G was placed at the center of the solution surface and 
found there was localization of fMENs surrounding the center of the applied field (Figure 
5A-bottom). Furthermore, the localization appeared to be within 2-3 mm in diameter with 
respect to the 1 mm tip of the conical-shaped Nd magnet.  This suggests MENs can be 











In a separate experiment, a uniform mixture of 5 mg/ml MENs-saline solution 
was prepared with an electrically sensitive fluorescent dye ANEPP-ormosil. We observed 
an increase in ANEPP fluorescent signals at both emission wavelengths 595nm and 
700nm when a ~450 G external field was applied (Figure 5B). No fluorescent signals 
were observed in solution that only contain ANEPP-ormosil dye with magnetic 
application and solution that contain ANEPP-ormosil dye plus MENs without magnetic 
application (Figure 5B). This suggests a weak external field can be used to induce MENs 
generation of electric field. 
 
 
Figure 5. External magnetic 
application induces MENs 
localization and electrical 
generation. A. fMENs can be drawn 
and localized around a permanent 
magnetic source in 0.1% 
Agarose:water solution. B. Activated 
fluorescence signal of electrically 
sensitive dye ANEPP-ormosil shown 
only when magnetic field is applied 
in the presence of MENs. MENs 
without magnetic application and 
magnetic application without MENs 
did not induce ANEPP fluorescence 
signals. 
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Magnetic stimulation of MENs enhanced neuronal activity in cultured and 
acute cortical slices. We first assessed the effects of magnetic stimulation of MENs on 
neuronal activity in organotypic cortical slices prepared from GCaMP6 transgenic mice.  
After the slices reached 5 days old in vitro, they were loaded with MENs, application of 
continuous magnetic wave (10 Hz for 10s sinusoidal waves at 450 G) resulted in a near 
200% increase in peak amplitude of calcium transients from individual neurons (Figure 
6A and B, F/Fo of 0.809 for baseline vs 3.586 for magnet on, p < 0.005, Repeated 
ANOVA, Tukey’s HSD). In slices that were initially active, there was a significant 
increase in calcium signals; whereas in slices that were not active, magnetic stimulation 
caused activation of calcium activity (Figure 6A and B). We also found dramatic gains in 
spike frequency during period when the magnet was turned on (2.6 spikes/cell) compare 
to baseline (1.43 spikes/cell) and after magnet was turned off (1.46 spikes/cell) (Figure 




In order to improve the temporal precision of the stimulation, asingle pulse 
(unipolar square pulse at 750-875 G with 200 ms duration) of magnetic wave was applied 
and tested the effect in acutely prepared cortical slices from GCaMP6 transgenic mice 
(Figure 7A-E). We found that evoked calcium response had much shorter latency period, 
with over 80% of responses occurring in less than 1 second, with the quickest response 
being ~75 ms (Figure 7A, C, D, and E).  The mean amplitude of calcium spikes at 
baseline was 0.127 ± 0.035, which became 0.541 ± 0.056 during magnetic stimulation, 
and returned to magnet was turned off (p < 0.005, Repeated ANOVA, Tukey’s HSD; 
Figure 7A, B).  This suggest unipolar magnetic wave can shortened neuronal response 
latency to MENs stimulation. 
 
Figure 6. Magnetic stimulation of MENs-loaded cortical slice cultures induced neuronal 
activity. Cultured cortical slices that expressed GCaMP6 in pyramidal neurons were loaded 
with MENS by adding 20 µl of 5 mg/mL MENs solution, followed by applying a conical 
permanent Neodymium (Nd) magnet for ~15 minutes. Magnetic stimulation was made with a 
pair of electromagnets at 10 Hz.  A. Representative two-photon images of calcium signals in 
periods before, during, and after magnetic stimulation. B. A sample trace of calcium transients 
measured from a neuron labeled with red circles in (A). C, D. Increases in average calcium 
spike amplitude (C) and number of spikes per cell (D) during the stimulation period. Calcium 
activity returned to baseline level after the magnet was off. Scale bar: 50 µm. *: p<0.05, **: 





Figure 7. Single unipolar magnetic pulses induced neuronal activity in MENs-
loaded cortical slices.  Cortical slices prepared from GCaMP6 transgenic mice 
were loaded MENs similar to Fig. 2 and stimulated with single pulses of magnetic 
field (~750-875 Oe at 200 ms pulse-width). A. Sample images of neurons in a slice 
and traces of calcium transients measured from the circled neurons. B. Average 
peak amplitudes of calcium spikes measured at baseline and after the magnets were 
turned on and off. C. Temporal response profile of all responding cells. D. Response 
latency of cells that between 0 and 500 ms after magnet was turned on. E. Percent 
distribution of response time from active cells ranges from less than 150 ms (t < 
0.15s), to between 150ms to 500ms (0.15s < t <0.5s), between 500ms and 1s (0.5s 
< t < 1s), and over 1s (t > 1s).    Scale bar: 50 µm, *p<0.005, Repeated-measured 




To examine the magnetic and electrical properties of MENs, functionalization of 
MENs with GMO was done to prevent particle agglomeration then applied strong 
magnetic field to an aqueous solution of fluorescently labeled MENs to assess its 
localization with respect to the magnet location. We found the localization of MENs 
towards a strong permanent magnetic field in the order of ~3500 G could be as small as 
2-3 mm in diameter surround the center of the field. Its electrical output was measured by 
applying a weaker external field in the presence of an ANEPP electrically sensitive dye 
and found ANEPP fluorescent signal increased only when during magnetic application.  
The ultimate goal of this study is to determine the effects of MENs stimulation, by a 
weak external magnetic field at the right frequency, on neuronal activity. We set out to 
test this hypothesis by first applying MENs to cultured organotypic GCaMP6 mice brain 
slices in vitro. Due to high amount of electromagnetic noise generated by the stimulating 
electromagnets, calcium imaging gave us the advantage of monitoring neuronal activity 
without any interference that would not be possible with electrical recording. Upon 
magnetic application, we observed dramatic increases in neuronal calcium response. This 
is a clear indication of the stimulatory effects of MENs on neuronal activity. Our results 
are consistent with previous reports of using BaTiO3 to activate neurons by either 
complexing this piezoelectric compound with a vibratory sensitive core of gum Arabic 
then stimulate with high intensity ultrasound42 or by direct stimulation with focus 
ultrasonic wave43. Furthermore, Marino et al. also performed sodium imaging and found 
the observed gain in activity was TTX-sensitive. With their ultrasound stimulation 
parameters however, their neuronal response times to the stimulation were in the order of 
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10th of seconds. Whereas the observed response time were sub-hundredth of milliseconds 
when a unipolar field is applied. By applying unipolar field, this enabled the resulted 
polarization to match more closely with the depolarization phase of an action potential 
thus resulted in quicker neuronal firing. Since calcium imaging signals are inherently 
limited by its slower kinetics than electrical signals and GCaMP6s signal is known to 
have a temporal resolution of 100-150 ms40, the actual latency is estimated to be 50 ms 
and less. This is a good temporal resolution and a clear indication of the stimulatory 
effects of MENs on neuronal activity. 
A big advantage of this technique compare to others is these MENs complex-
containing the robust piezomagnetic core material CoFe2O4, which enables full control of 
particles localization. My next aim is to assess whether MENs can be directed through 
the BBB and localize to a brain region with minimal toxicity. Then further evaluation of 




Chapter 3 – MENs can be drawn across BBB and localized in brain cortex with 
minimal toxicity 
Introduction 
The blood brain barrier (BBB) represents an important physiological barrier that 
serves as a defense mechanism against harmful foreign pathogens/various toxic 
chemicals. However, the BBB also represent a physical barrier preventing effective 
targeting of the brain parenchyma with diagnostic and therapeutic agents. Targeting 
through BBB is a clinically important, yet difficult goal to achieve in developing 
therapeutic technologies44.  
  Nanoparticle-based molecular transport has been the focus of recent strategies to 
enhance delivery and reduce toxicity in many diverse fields34, 45, 46. Magnetic-based 
nanoparticles in particular have been an important focus of these developments. This is 
due to their unique properties to respond to magnetic fields as well as their safety, i.e. 
their usage as MRI contrast agents34, 47. However, magnetic nanoparticles applications to 
the central nervous system, particularly the brain, have been very limited, due in part to 
the adverse effects of nanoparticles when subject to external field for long period of time, 
for example the overheating effects31 or the demagnetization (i.e. loss in magnetic 
response)33, 48 of particle itself. There are also the FDA limitations of applied magnetic 
field strength on human patients (~80k G or 8 T for adults and 40k G or 4 T for 
children)49. Therefore, more efforts have focused on developing magnetic nanoparticles 
that can withstand long duration of applied magnetic field without alteration of their 
intrinsic properties as well as particles that can be localized efficiently with a weaker 
applied field50, 51. Majority of these studies have focused on cancer animal models in the 
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periphery or drug targeting to various organs52, 53, 54. 
 MENs with the iron oxide ferromagnetic core, which complexed with a central 
cobalt atom, enhancing their magnetorestrictive response to a weaker applied magnetic 
field while enable it to retain its properties without demagnetization35, 36. This makes 
MENs a good candidate for targeting across BBB using weaker magnetic field and 
localize it to a brain area. Our aim is to determine whether MENs can be directed across 
BBB to the brain and to characterize its spatial and temporal profile. We also assess their 




In vivo vascular fMENs imaging. Animal preparation: Thy1-GCaMP6s mice 
(n=5) were anesthetized with (87.3 mg/kg / 13.7 mg/kg) Ketamine/Xylazine mixture and 
the scalp was removed. A cranial window (3 mm in diameter) was made, in one cortical 
hemisphere, of an area 1.5 mm lateral from midline and 1 mm posterior from bregma. 
Two pieces of cover glass (a 3-mm diameter glass adhered to a 5-mm diameter glass) 
were glued together with cyanoacrylate glue with the 3-mm glass facing the brain 
surface. After the glass was installed on the cranial window, an L-shaped titanium head-
plate was also glued on the posterior region of the head for head fixation during imaging. 
The animals were allowed to recover for 7 to 10 days. MENs injection: single injection of 
200 µL fMENs at 5 mg/ml retro-ortibally was performed. Two-photon imaging (as 
describe in method section of chapter 2) was done of cerebral blood vessels above the 
cortical area were taken at baseline, and 0, 5, 10, 20, and 30 minutes after fMENs 
injection. 
In vivo fMENs imaging to determine particle localization. Using GCaMP6 
mice with prepared-windows as described above, a single injection of 200 µL fMENs at 5 
mg/ml retro-orbitally was performed. Two sets of stacked cylindrical magnets of 6000 G 
field strength were applied to draw the MENs towards windows area for 10 minutes. The 
cylindrical magnets were then replaced by a 5000G conical magnet to further localize the 
MENs. Images were taken at various time points: before fMENs injection, after fMENs 
injection, after fMENs injection with drawing magnet application, and 24 hours post 
treatment. Animals were then euthanized and brain were dissected. Brain were then 
section into 250 µm thick slices and imaged immediately to assess nanoparticles 
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localization. All imaging was done with two-photon microscopy, procedure similar to 
described above. 
Immunofluorescence analysis of astrocytes and microglias. To determine 
potential glial reactivity and neuroinflammation induced by the MENs, we used an 
antibody against ionized calcium binding adaptor protein (IBA1) to label microglia, and 
an antibody against Glial Fibrillary Acidic Protein (GFAP) to label astrocytes55, 56. MENs 
treatment: C57BL6J mice (n = 4 animals/group) were assigned into three groups: control 
(saline injection + magnetic stimulation), MENs-treated (MENs without magnetic 
stimulation), and MENs-treated with magnetic stimulation (MENs+ms). MENs-treated 
only group was subjected to ~6000 G Neodymium (Nd) magnets placed above and below 
one brain hemisphere to draw the particles to that hemisphere. MENs-treated with 
magnetic stimulation group was subjected to both the Nd drawing magnets and also two 
electro-magnetic magnets for five 2-minutes duration stimulation period at 10 Hz, with 
each period separated by five-minutes break gap. Within the MENs-treated+ms group, 
subgroups of mice were then euthanized at various time points after treatments (4 hours, 
24 hours, 3 days, and 1 week). Animal perfusion/ Brain sectioning: mice were deeply 
anesthetized with (87.3 mg/kg / 13.7 mg/kg) Ketamine/Xylazine and perfused 
transcardially with PBS buffer (0.01 M phosphate saline PBS, 80ml) followed by 4% 
formaldehyde PFA (150 ml) at room temperature. The brains were then dissected and 
placed in 30% sucrose for 48-72 hours at 4oC. The tissue was then frozen in O.C.T 
Compound (Sakura Finetek, Torrance, CA) at -80 oC, and sectioned at 40 µm thickness 
coronally with a cryostat.  Immunofluorescence was performed on free-floating sections 
as followed: After the brain sections were washed four times with PBS, then incubated 
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with blocking solution (5% Normal Goat Serum, 0.1% Triton, 1% BSA) for 1 hour at 
room temperature, they were incubated overnight with a primary antibody. Brain sections 
were then washed the next day and incubated with fluorescent goat anti-rabbit secondary 
antibody for two hours. For nuclear staining, 4’, 6-diamidino-2-phenylindole (DAPI; 1: 
10,000) was added to the solution for a final 5 minutes. Finally, slices were washed three 
times with PBS and mounted and imaged using a Neurolucida confocal imaging system. 
Primary anti-GFAP (mouse; 1:800, Sigma Aldrich G3893) and anti-IBA1 (goat; 1:200, 
ABCam ab5076) antibodies were used to labeled astrocytes and microglias respectively, 
which were followed by secondary antibodies of goat anti-mouse Cy5 (1:500, Jackson 
Immuno) and donkey anti-goat 488nm (1:1000, Fischer Scientific). 
Statistics. Mean values and final plots were developed in Microsoft Excel.  All 
statistical analyses were done with Jmp Analysis 11 (SAS Institute Inc. 2013. Cary, NC), 
and GraphPad Prism 6 (GraphPad Software, La Jolla, California). One-way ANOVA 
analyses were used for comparing positive stained cells between groups of IBA1 and 
GFAP immunohistochemistry experiment. For comparisons that yield statistical 





MENs remained in the blood stream up to 30 mins post-injection. After 
injecting fMENs into the tail vein of mice, repeated two-photon imagings were done to 
track the changes in fluorescence intensity in the cortical vascular network. There was 
high level of fMENs in blood stream immediately after injection, which decreased 
rapidly over a short period of time (Figure 8A-B). The fluorescence intensity in blood 
stream dropped to about 50% in less than 15 minutes and was completely abolished in 
about 30 minutes post injection. This suggest that the optimal time window for applying a 

















Magnetic delivery of MENs to brain. To assess the effectiveness of using strong 
permanent magnet to deliver MENs to the brain, fluorescence-labeled MENs (fMENs) 
were delivered by injecting through retro-orbital vein to mice with cranial windows, then 
applied a cone- shape Nd magnets of strength ~3500-4500 G above and below the head 
for 20 minutes. In vivo two-photon imaging showed that fluorescence signals were visible 
through cranial windows in mice with fMENs and magnet attraction, but not in mice with 
MENs injection only, suggesting that the fMEN were drawn by a magnetic field to cross 
BBB and entered brain parenchyma in vivo (Figure 9A-B). When the same mice were 
imaged 24 hours later, there remained about 70% fluorescence signal in the same brain 
Figure 8. In vivo delivery of fMENs into blood vessels. A. Vascular MENs level 
reduced after 10 mins post injection.  In vivo two-photon images of cortical blood 
vessels were taken at baseline (B.L.) and at 5, 10, 20, and 30 mins after intravenous 
injection of 10 µg fluorescence labeled MENs (fMENs). No magnetic field was 
applied. B. Measured fluorescence signal of fMENs in blood vessels. Scale bar: 100 
µm. 
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region, suggesting that a significant amount of fMENs remained in cortical tissue at 24 
hours after delivery. Finally, when the same animal was perfused after last imaging time 
point and cortical coronal slices were section, we observed significant level of fMENs at 
the upper cortical surfaces (Layers 1-4 of cortex) with some detected at deeper layer, 
mainly in the hemisphere where the magnet applied (Figure 9C). The opposite 
hemisphere of the same brain slice showed only minute traces of fMENs. This suggest 
magnetic localization parameters can efficiently direct fMENs close to one brain 






















Figure 9. In vivo delivery of fMENs into mouse cortex. A. In vivo two-photon 
images of layer 2/3 sensorimotor cortex were taken at baseline (C1) and after (C2) 
intravenous injection of 10 µg fMENs, after applying ~4000-5000 Oe magnetic field 
for 45 minutes (C3), and on the second day after injection (C4) indicates successful 
delivery of MENs to cortical tissue after magnet application, which MENs remained 
up to at least 24 hours after delivery. B. Measured fluorescence signal of fMENs in 
brain tissue. C. Confocal images of mous cortex showed high level of fMENs in 
cortical hemisphere where magnet is applied Scale bar: 100 µm.     
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MENs treatment with magnetic stimulation resulted no change in astrogliosis 
and microglial activation. Delivering MENs to a specific brain region may initiate 
inflammatory responses of glial cells, particularly astrocytes and microglias (Figure 10A-
H). To assess whether astrogliosis and microglial activations occurred, we made 
intravenous injection of 200 µl of MENs at 200 µg/ml and magnetic delivery of MENs. 
Mice that received MENs delivery and MS were also assessed at various time point after 
the stimulation. There were no significant differences in the densities of both IBA1 and 
GFAP positive cells up to one week among all the groups (Figure 10 A-C, G, H). 
Considering these results together, MENs-MS did not induce any apparent inflammatory 










Figure 10. No significant changes in the numbers of GFAP and IBA1 positive cells 
after MEN delivery and MENs-MS. Brain sections were obtained from six groups of 
C57BL mice including MS control, MENs-delivery (MENs), and MENs delivery followed 
by MS at 4h, 24h, 2 days, and 1 week after. A-F. Sample confocal images of coronal 
cortical slices stained for DAPI, GFAP, and IBA1 at different time points. G, H. 
Quantifications of GFAP (G) and IBA1 (H) positive cells showed no significant differences 
in the numbers of these cells after MEN delivery or followed by MS. n = 4 mice/group. 




MEN’s ability to be attracted to a strong permanent field was further tested in vivo 
by injecting the nanoparticles into the blood stream and drawn them towards one brain 
hemisphere with the permanent magnet. MENs can be drawn across BBB and strictly 
localized to one hemisphere where the magnet is applied above the skull area of that 
hemisphere. This presence of MENs remained in the brain tissue up to at least 24 hours 
after treatment. Furthermore, earlier reports have also shown that these MENs, after 
being drawn across BBB, appear to localize mainly on the extracellular side both in the 
CSF57 and binding to extracellular membranes of various type of CNS residential cells35, 
57. However, there are also evidence of MENs distribution in cell cytosol57. It was also 
found that the chemical structure and integrity of MENs were not compromised during 
this process of navigation from the blood stream across the endothelial cell layers of the 
BBB to be localized in the brain57. After a single IV injection of MENs without magnetic 
field application, MENs retained in the vasculature up to 30 minutes but dissipated 
quickly. This suggests immediate application of permanent magnetic field right after 
MENs injection for at least 30 minutes is required to ensure maximum delivery of MENs 
to the brain tissue.  
In CNS, we assessed neuro-inflammatory response to MENs by treating animals 
with MENs and evaluate their microglial and astrocytic activations at multiple times 
point after MEN treatment and magnetic application. No significant changes in microglial 
activation nor astrogliosis were observed in mice injected with MENs then drawn with 
magnets compare to mice that were only injected with MENs without magnet application 
as well as control mice with only saline treatment combine with magnetic application. 
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Furthermore, IBA1 and GFAP levels remained at similar level, up to 1 week, compared 
to control group. In addition to our findings, Kaushkik et al. also reported no changes in 
peripheral immune response, liver and kidney toxicity, nor abnormal behavioral changes 
up to one week after MENs treatment with magnetic drawing towards the brain cerebral 
cortex57. Taken together, these results provide encouraging information on the safety of 
MENs to the biological system that therefore can potentially be applied for translational 
research and clinical treatment.  
Understanding the spatial and temporal distribution of MENs in an in vivo system 
in combination with the observed stimulatory effects on in vitro cultured neurons, the 
next aim is to assess MENs effects on neuronal activity in a living animal. Our 
observation of MENs targeted to one cortical hemisphere and remained there for at least 
24 hours raises additional questions of whether the stimulatory effects of MENs in vivo, 
if true, will last for at least 24 hours after single treatment? And will the effects be only 
localized to the hemisphere where particles presence was observed? Chapter 4 will go 
into detailed of the experiments we conducted to answer such questions. 
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Chapter 4 MENs stimulation enhance cortical neuronal activity in vivo that lasted 
up to at least 24 hours  
Introduction 
In the past 30 years, modern noninvasive brain stimulation techniques have made 
remarkable contributions to the research, diagnosis, and treatment of many neurological 
diseases. Ranging from clinically used transcranial electrical stimulation (TES) to 
magnetic stimulation (TMS) to recently developed research-only optogenetics and focus 
ultrasound stimulation (FUS), non-invasive brain stimulations have made great strides in 
advancing neuroscience. These, however, are often limited by the relatively low spatial 
and temporal resolution (TES, TMS)14, 15, 58, required genetic modification 
(optogenetics)19, scarce penetration into the deeper brain regions (TES, optogenetics), 
and unquantified detrimental adverse effects (FUS)26, 27. Another approach that well-
characterized and well-used in the clinical settings are represented by deep brain 
stimulation (DBS).  This has shown to be very effective in a targeted, localized 
modulation of functions of a brain region. But the technique comes with the cost of risk 
due to its invasive surgical operation followed by long-term inflammation and gliosis at 
the surgical site59. 
The landscape of nanoparticles applications in neuroscience, particularly neural 
stimulation, is still in its infancy with many optimizations needed to be done. Specially, 
non-invasive neural stimulation with nanoparticles are still in its early stages of proof-of-
concept studies and in vitro demonstrations, which are promising but not yet 
translatable33, 42, 60. MENs hold promising potentials observed both in our study and 
others35, 57, to be targeted across BBB and localized to a relatively small brain region with 
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minimal toxicity. Furthermore, promising MENs stimulation of neuronal activity 
observed in vitro (Chapter 2) encourages us to examine its effects in an in vivo system as 




In vivo calcium imaging of cortical neurons in GCaMP6 transgenic mice. 
Animal preparation: Thy1-GCaMP6s mice (n=5) were anesthetized with (87.3 mg/kg / 
13.7 mg/kg) Ketamine/Xylazine mixture and the scalp was removed. A cranial window 
(3 mm in diameter) was made, in one cortical hemisphere, of an area 1.5 mm lateral from 
midline and 1 mm posterior from bregma. Two pieces of cover glass (a 3-mm diameter 
glass adhered to a 5-mm diameter glass) were glued together with cyanoacrylate glue 
with the 3-mm glass facing the brain surface. After the glass was installed on the cranial 
window, an L-shaped titanium head-plate was also glued on the posterior region of the 
head for head fixation during imaging. The animals were allowed to recover for 7 to 10 
days. MENs treatment: After the animals were sedated via intraperitoneal injection of 
chloprothixene (0.04 mg/ml) and isofluorane, they were injected retro-orbitally with 200 
µl CoFe2O4-BaTiO3 –Texas Red (fMENs) at 5 mg/ml. MENs localization paradigm is 
similar to described above: two sets of stacked cylindrical magnets of 6000 G field 
strength were applied to draw the MENs towards windows area for 10 minutes. The 
cylindrical magnets were then replaced by a 5000G conical magnet to further localize the 
MENs for 15 minutes.  Following the delivery of the MENs, the animal’s head was 
stabilized by fixing the L-shaped titanium metal plate to a custom-made base and the 
body temperature was maintained. Magnetic stimulation was made by placing two 
electromagnets (~500 ms pulse-width at ~300-450 G) closely on each side of the head. 
Low power images show the pattern of blood vessels on brain surface were captured. 
Two-photon images of calcium transients of layer II/III neurons were taken at baseline, 
during magnetic stimulation, and after magnetic stimulation was turned off. We tested a 
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combination of different stimulation frequencies (5, 10, 20, 50, and 100 Hz). In each 
imaging field, two optical planes in layer II/III were imaged for 2 minutes at 4-5 frames 
per second (fps). 
Mesoscopic whole brain imaging windows preparation. Thy1-GCaMP6s 
transgenic mice were anesthetized with (87.3 mg/kg / 13.7 mg/kg) Ketamine/Xylazine 
mixture and the scalp was removed. After a large cranial window (approximately 10 x 8 
mm) was made by removing the skull, a piece of curved cover glass was installed and 
tightly sealed with super glue and dental cement. The animals were allowed to recover 
for 7 to 10 days prior to imaging. Mesoscopic imaging set-up used is similar to previous 
developments61, 62. In brief, whole brain calcium activity was imaged with a system 
consisting of a Leica DM6000 FS upright microscope with a Leica EL-6000 120W 
mercury fluorescence light source directed onto the prepared glass skull surface. Images 
were capture with a two-lens system composes of a top zoom Nikkor 70-300mm of 
aperature f3.5-5.6 set for 70mm at f3.5 couple through an inverted lens adapter to a 
bottom Nikkor 50mm prime at f1.4. Videos were capture with an iXON EMCCD DU-
88U camera system (Andor USA, Concord, MA). Delivery of MENs and magnetic 
stimulation paradigm are done exactly as described in two-photon imaging. 
C-fos staining of cortical neurons. C57BL6J mice (n = 4 animals/group) were 
assigned into three groups: control (saline injection + magnetic stimulation), MENs-
treated (MENs without magnetic stimulation), and MENs-treated with magnetic 
stimulation (MENs+ms). MENs-treated only group was subjected to ~6000 G 
Neodymium (Nd) magnets placed above and below one brain hemisphere to draw the 
particles to that hemisphere. MENs-treated with magnetic stimulation group was 
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subjected to both the Nd drawing magnets and also two electro-magnetic magnets for five 
2-minutes duration stimulation period at 10 Hz, with each period separated by five-
minutes break gap. Brain tissues of these mice were stained for c-Fos protein, an 
indicator of action potential firing63. Animal perfusion/ Brain sectioning: Four hours post 
treatment, mice were deeply anesthetized with (87.3 mg/kg / 13.7 mg/kg) 
Ketamine/Xylazine and perfused transcardially with PBS buffer (0.01 M phosphate saline 
PBS, 80ml) followed by 4% formaldehyde PFA (150 ml) at room temperature. The 
brains were then dissected and placed in 30% sucrose for 48-72 hours at 4oC. The tissue 
was then frozen in O.C.T Compound (Sakura Finetek, Torrance, CA) at -80 oC, and 
sectioned 40 µm thickness coronally with a cryostat.  Immunofluorescence was 
performed on free-floating sections as followed: After the brain sections were washed 
four times with PBS, then incubated with blocking solution (5% Normal Goat Serum, 
0.1% Triton, 1% BSA) for 1 hour at room temperature, they were incubated overnight 
with a primary antibody for c-Fos (rabbit; 1:800, Sigma Aldrich G3893). Brain sections 
were then washed the next day and incubated with fluorescent goat anti-rabbit secondary 
antibody (1:200; Invitrogen, Carlsbad, CA) for two hours. For nuclear staining, 4’, 6-
diamidino-2-phenylindole (DAPI; 1: 10,000) was added to the solution for a final 5 
minutes. Finally, slices were washed three times with PBS and mounted and imaged 
using a Neurolucida confocal imaging system. 
Statistics. Mean values and final plots were developed in Microsoft Excel, Jmp 
Analysis 11 (SAS Institute Inc. 2013. Cary, NC), and GraphPad Prism 6 (GraphPad 
Software, La Jolla, California). All statistical analyses were done with Jmp Analysis 11 
and GraphPad Prism 6. ANOVA analyses were used for comparing calcium amplitudes 
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of the same group across different time points (Repeated measures Anova), amplitudes 
and frequencies of calcium imaging data (one-way), compare of calcium amplitudes and 
frequencies across different tested magnetic frequencies and different cortical region in 
mesocopic imaging (one-way), and compare of positive stained cells between groups of 
c-Fos immunohistochemistry experiment (one-way). For comparisons that yield 
statistical significance, Tukey’s HSD post-hoc analyses were applied for further 




MENs treatment with magnetic stimulation increased GCaMP6 cortical 
neuronal calcium activity in vivo. in vivo two-photon imaging in GCaMP6 transgenic 
mice was done to assess whether MENs-MS increases cortical neuronal activity. There 
was a dramatic increase in the mean total amplitude of somatic calcium spikes (F/Fo of 
2.37 vs 1.50 for baseline and 1.36 for magnet off, Figure 11A, C) with p<0.0001, both 
cases and response frequency (3.08 spikes/cell vs. 1.96 for baseline with p=0059 and 1.54 
for magnet off with p<0.0001, repeated ANOVA, Tukey’s HSD, Figure 11D).  Dendritic 
calcium transients also showed similar increased fluorescence amplitude and cell spiking 
patterns with MENs stimulation (Figure 11A, E, and F). These data provide strong 





Figure 11. Magnetic stimulation activated cortical layer II/III neuron in vivo.  A-B. 
Representative images (A) and traces (B) of calcium transients measured from layer II/III 
cortical neurons. C-D. Significant increases in average calcium spike amplitude (C) and mean 
spike number (D) of cortical neurons after magnet stimulation was turned on. D-F. Significant 
increases in average calcium spike amplitude (E) and mean spike number (F) of cortical 
dendritic arean = 5 mice, *p <0.05, one-way ANOVA, Tukey’s HSD. 
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Furthermore, various magnetic frequencies of 5, 10, 20, 50, and 100 Hz were used 
during the stimulation period, after the magnets were turn off, and ten minutes after they 
were off. For every magnetic frequency applied during the stimulation period, there were 
significant increases in both somatic and dendritic calcium spike amplitude (Figure 6D, 
Figure 7D) and spike frequency (Figure 12A). Interestingly, it appeared that the highest 
neuronal response (i.e. highest average spike amplitude and frequency) to the stimulation 
were at 5, 10 and 20 Hz stimulation frequencies (Figure 12A-B). 10 Hz frequency was 
picked as the standard for in vivo stimulation in most of experiments of our study. 
 
 
Single MENs treatment with magnetic stimulation increased in vivo 
GCaMP6 cortical neuronal calcium activity at targeted areas for up to at least one 
day after treatment. Multiple brain stimulations over a period of time may be required 
to achieve treatment effect in certain neurological diseases. To evaluate this, we gave 
animals a single MENs delivery, and then performed MS and calcium imaging at 
Figure 12. Magnetic stimulation efficiently activated cortical layer II/III neuron in vivo 
between 5-20Hz of applied magnetics frequencies. A-B. Increase in average calcium spike 
amplitude (A) and total spikes per cell (B) of cortical neurons when magnet was turned on at 
each frequencies of stimulations. Changes in the amplitudes and spike numbers of calcium 
transients at electromagnetic stimulation frequencies of 5, 10, 20, 50, and 100 Hz.  The data 
indicate that magnetic waves between 5-10 Hz were most effective in stimulating neurons in 
vivo. n = 5, *p <0.05, **p<0.01, two-way ANOVA, Tukey’s HSD. Scale bar – 100um 
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different time points (Figure 12,13). When comparing calcium responses across all time 
point during period of magnetic application, there was a large increase in the amplitude 
of calcium spikes when MS is applied immediately after MENs delivery, when compared 
with baseline where magnet was applied without MENs treatment (mean F/Fo of 2.7 ± 
0.27 vs 1.13 ± 0.07 of baseline, p < 0.05, one-way ANOVA, Tukey’s HSD, Figure 12B, 
D). Neuronal activity could still be stimulated with similar parameters of MS at 24 hours 
after MENs delivery (F/Fo of 2.35 ± 0.28, p<0.05, one-way ANOVA, Tukey’s HSD), but 
not at 72 hours after (Figure 13D. F/Fo of 1.21 ± 0.18, p>0.05, one-way ANOVA). There 
also was higher number of active cells after MENs treatment up to 24 hours (~90 cells of 
MENs+ms and 82 cells of 24 hours vs. 62 of ms-only baseline, Figure 13C), and recover 
to baseline level at 72 hours (~55 cells, Figure 13C). Individual time point results also 
showed increased in calcium amplitude when magnetic field was applied only in 
MENs+ms group and 24 hours after (Figure 14A-D). The result suggests that a single 




Figure 13. MENs-MS was effective in activating neurons in 24 hours after a single 
delivery of MENs. A-B. Representative two-photon images and traces of calcium signals 
of same cortical layer II/III neurons at baseline (MS only) and immediately after MENs 
delivery followed by MS (MEN+MS), MS at 24 hours after, and MS at 72 hours after. 
10Hz magnetic stimulation was applied for 20s in the middle of recording period at each 
time point. C. There was an increase in number of active neurons after MENs-MS, which 
remained higher up to 24 hours after initial delivery. D. There were increases in response 
amplitude immediately after MENs-MS and at least 1 day after initial delivery, which 
returned to baseline level at 3 days post-MEN delivery, one-way ANOVA, Tukey‘s HSD, 






To assess the effect of MENs-MS on global network activity, we applied 
mesoscopic brain imaging technique to evaluate hemispheric calcium response in 
GCaMP6 transgenic mice (Figure 15A-F). The epicenter region was defined as the 
location where a permanent magnet was applied to draw MENs to a local cortical region 
(Figure 15A). Application of 10 Hz magnetic wave induced cortical calcium spikes with 
significantly higher amplitude and varying latencies in the epicenter and contralateral 
cortex (p<0.05, repeated ANOVA, Tukey’s HSD, Figure 15B, C). Comparing the 
responses among the epicenter and different ipsilateral and contralateral cortical regions 
revealed a highest peak amplitude at the epicenter and gradual reduction in amplitude 
Figure 14. Increased in neuronal activity observed only in MENs treated group 
immediately after treatment and 24h later. A-D. No change in calcium response 
amplitude in magnetic stimulation group without MENs treatment (A). Increase in 
response amplitude immediately after magnetic stimulation only immediately after 
treatment (B) and at 24 hours later (C). At 72 hours after treatment, no significant 
increase in response amplitude. one-way ANOVA, Tukey‘s HSD, n=5, *p <0.05.  
 
 54 
(p<0.05, one-way ANOVA, Tukey’s HSD, Figure 15D, E, and F) and increase in latent 
period (Figure 15D, G, and H) at locations further away from epicenter. The results 
suggest that neuronal activity was initiated at the epicenter where MENs are localized 
and spread to more distal brain regions and the contralateral cortex. These data provide 












MENs treatment with magnetic stimulation increased cortical c-Fos expression. 
There was an increase in cortical c-Fos-positive cells only for animals that has both 
MENs treatment and magnetic stimulation, average of 176±27.5 cells/counted region vs 
70.5±15.25 for MENs only group and 51±8 for control. MENs treatment-only animal and 
magnetic stimulation-only naïve retained similar levels (Figure 16A, B). Taken together, 
this further supports the MENs+ms stimulatory effect findings observed in calcium 
imaging experiments. 
 
Figure 15. Mesoscopic activity imaging revealed initiation and spreading of MENs-MS 
induced cortical activity in vivo.  A-B. Representative images (A) and traces (B) of calcium 
transients measured from both hemispheres at baseline (left image) and after turning on and 
off magnetic stimulation (middle and right images).  The epicenter was a cortical region 
where a conical magnet was applied to attract MENs. Dotted lines indicate the start of 
calcium spike. C. There were significantly higher amplitudes of calcium signals on cortex 
ipsilateral (at epicenter region) and contralateral (same region on opposite hemisphere) to 
MENs delivery induced by MS (10 Hz at 450 Oe for ~30 seconds). n = 5, *p <0.05, repeated-
measured ANOVA, Tukey’s HSD. D. Sample traces of calcium transients measured from 
epicenter, cortical regions anterior and posterior from epicenter, and areas of contralateral 
cortex. E, F. The mean amplitude of calcium signals in the epicenter was higher than that of 
cortical regions more anterior or posterior to it; the contralateral cortex had similar 
differences.  G, H. The latency period at the epicenter was the shortest than all other cortical 





Figure 16. MENs-MS increased the number of c-fos expressing cells. A. 
Representative images of immunofluorescence from mice that received magnetic 
stimulation (MS, top row), MENs delivery only (middle row), or MENs+MS (bottom 
row). Images were taken with an 20x objective. B. A significantly higher density of c-Fos 
expressing cells in MENs+MS group than either MS only or MENs only group. Scale bar:  




We further tested MENs stimulatory effects in vivo by injection of particles into 
mice then applied a strong permanent magnetic field to draw them to a cortical area. A 
weaker electro-magnet for stimulation was applied. Because magnetic stimulation using a 
pair of electromagnets generates a high level of electromagnetic noise, calcium imaging 
technique was used to record neuronal activities instead of using electrophysiological 
recording. Furthermore, Calcium imaging also allow us to efficiently examine neuronal 
activities not only in individual neurons in vivo and in vitro but also in both cortical 
hemispheres. By repeating the calcium imaging experiment, there was significant 
increase in calcium transient amplitude and response frequency only during the period in 
which the magnet was turned on. This increase was not only observed at somatic area but 
also at dendritic area as well. Furthermore, the gain in calcium transient amplitude 
retained significantly above baseline level for every magnetic stimulation frequency. 
Calcium response frequency also increased, where the most dramatic gains were seen 
between 5 and 20 Hz magnet frequencies. This suggests the stimulatory effects of MENs 
on cortical neurons not only exists at cell body’s activity level but possibly also at the 
synaptic activity level. Whole brain mesoscopic imaging revealed activity changes in a 
spatially dependent manner relative to the location of MENs. We further assessed the 
longitudinal profile of MENs effects on neuronal activity and found their stimulatory 
effects lasted for at least one day post single treatment and dissipated after three days. In 
addition to functional assessments, stained mice cortical brain slices were also stained for 
c-Fos expression, a classical indicator of excitability (e.g. action potential firing)63 that 
would further support the MENs’s stimulatory effect on neuronal activity. Comparing to 
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sham and MENs-treated only animals, there was a very large increase in cortical c-Fos 
expression level only in animals that were subjected to both MENs injection and 
magnetic stimulation. In contrast, there was no change in c-Fos level in MENs-treated 
only animals compare to sham. 
To our knowledge, this study is the first study that reports the stimulatory effects 
of magnetic-electric based nanoparticles on neuronal activity in vivo both at single-cell 
level as well as large brain regions via calcium imaging. Previous reports by investigators 
at FIU also found increase in EEG responses during magnet-on period in animals treated 
with MENs but return to baseline when magnet was turn off35. When testing with a 
control non-electric nanoparticles, in which, the particles only consist of the CoFe2O4 
core but the electric-generative BaTiO3 perovskite shells were absent. These 
nanoparticles retained their ability to be attracted to a strong magnetic field but lacking 
their electrical current-generated property. It was reported that there is no change in EEG 
response when magnet was turn on at various stimulation frequencies. Taken together, 
these results demonstrate a very useful and potentially ground-breaking ability of MENs 
to enable precise control of neuronal activity both in vitro and in vivo.  
The study’s goal was to demonstrate as a proof-of-concept the ability of MENs to 
be localized in the brain and efficiently activated and enhanced neuronal activity. 
Although MENs stimulation can efficiently enhances cortical neuronal activity, it was not 
sufficient to induce down-stream motor response when we preliminary tested on 3 
animals. This is partially due to the required synchronized large population firing of 
motor cortical neurons in order to evoke muscle movements64. Additionally, once MENs 
is drawn to a cortical hemisphere, applied external magnetic field facilitated MENs 
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stimulatory effects all neurons in the area. This include both excitatory and inhibitory 
neurons. Furthermore, the act of imaging the calcium activity in Thy-1-GCaMP6 
expressing neurons only allow us to visualize activity of excitatory synapses. Thus, the 
enhancement in cortical neuronal activity observed should not be expected to produce 
down-stream motor response due to the possible enhancement of inhibitory neuronal 
activity by MENs that off-set total cortical response.  In order to facilitate down-stream 
evoked motor response, we need to further exploit the potential of MENs to improve its 
stimulatory efficacy. Thus, additional effort is being made to precisely localize more 
MENs to a smaller area of the brain, even towards cell-type specific localization to 
enable extreme focal neural modulation. This recent work will be discussed in the last 
chapter of this dissertation. Due to MENs promising potential as the next non-invasive 
stimulation approach, we proceed with testing its effects on a neuropathic pain disease 
model. The following chapter 5 focuses on the first confirmed ability of MENs 
stimulation in relieving neuropathic pain, its potential application to other disease types, 
and further optimizations for improve therapeutic efficacy. 
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Chapter 5 MENs stimulation at acupuncture points diminishes nociceptive 
responses in tibial nerve transection mouse model 
Introduction 
The International Association for the Study of Pain (IASP) classifies neuropathic 
pain (NP) as pain “initiated or caused by a primary lesion or dysfunction in the nervous 
system”65. NP afflicts millions of people worldwide. This is due to many common 
diseases, injuries, and adverse effects from medical procedure cause NP by producing 
lesion in somatosensory pathways of the central or peripheral nervous system66, 67. 
Current pain management of chronic NP is complex and existing treatments are often 
inadequate. 
Classically, NP results from a primary lesion induce central and/or peripheral 
sensitization of the nervous system6. This, in turn, produces spontaneous, random, and 
uncontrollable hyper-excitability of neurons. Therefore, traditional approach to NP 
therapeutics has mostly aimed to reduce or block neuronal activity. Treatments ranging 
from blocking voltage-gated sodium (VGSCs) or calcium channels (VGCCs) with 
carbamazepine and gabapentin, respectively, to specific receptors inhibitors like 
serotonin and norepinephrine (selective serotonins and norepinephrine reuptake 
inhibitors, SSNRIs) are used widely5. A riskier approach of targeting other modulating 
pathways has shown effective in pain management but come at great cost of increase in 
drug tolerance, which often lead to misuses and addiction (i.e. opioid-based analgesics 
such as codeine, fentanyl, tramadol, morphine)5. Surgical approaches (thalamotomy and 
various tractotomies) aim to interfere with the pain signaling pathway has also been 
increasingly recommended by health-care provider, though as last resorts6.  
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An emergent advancement in understanding pain mechanism hypothesizes that 
overcompensation of an innate nervous system response to lesions (a process called 
homeostatic plasticity) that may give rise to NP68, 69. Synaptic plasticity involves as a 
regulator for activity by either strengthening the synapses (long-term potentiation, LTP) 
or weakening the synapses (long-term depression, LTD)70. For example, in a healthy 
individual, a homeostatic response is elicited when two electrical stimulations are applied 
at short intervals to the cortex71. This phenomenon is observed as an initial increase in 
cortical excitability after the first stimulation (synaptic strengthening) that is then 
followed by a decrease in excitability and reverse towards inhibition (synaptic 
weakening) when the second stimulation is applied. In this way, the nervous system 
corrects for exposure to excessive level of excitation and prevent aberrant synaptic 
plasticity71, 72.  
Evidence from animal models of pain and conditions such as migraine and 
muscular dystonia after injury in human suggest a link between impaired homeostatic 
plasticity and symptoms. In injured animals, the primary lesion caused by the injury 
produces acute loss in neuronal activity, which resulted in chronic hyper excitability that 
contribute to long-term pain69, 73, 74. An abnormal nervous system after trauma gives rise 
to an impaired homeostatic plasticity regulation, which resulted in inappropriate and 
excessive compensations. This is evidenced by more recent counterintuitive approaches 
that shown to effectively reduce hyperalgesia via stimulations6, 18. Electrical stimulations 
of multiple locations along the pain signaling pathways6 or cortical brain stimulation with 
magnets, TMS18 produce promising results in patients reporting pain relief. Optogenetics 
stimulation in animal models was also shown to very effectively increased nociceptive 
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threshold69. Unfortunately, these reliefs are partial and short-term. Eastern traditional 
approaches like acupuncture has also been shown to partially relieve both central and 
local pain, with electro-acupuncture results in even better efficacy in both animal models 
and human patients75, 76, 77, 78, 79. 
Due to MENs promising potential, we sought to determine the effects of MENs 
treatment combining with magnetic stimulation of tibial nerve transection mouse model. 
Tibial nerve injury reliably produces local and long-term pain in rodents69, 80, 81, 82 and 
past efforts have shown that local treatment using electroacupuncture76 and injection of 
drug into acupuncture point83 seems to effectively reduce stimulus-dependent 
hyperalgesia. Our plan was to inject MENs to a well-known acupuncture point, which is 
often used to reduce nociception in human and perform the magnetic stimulation to 




Fluorescent MENs (fMENs) treatment to acupuncture point. Preparation of 
CoFe2O4-BaTiO3 -Texas Red, fluorescent MENs (fMENs): Texas Red NHS ester was first 
reacted with oleylamine (2:1 molar ratio) for 18-24 hours on a rotator in a dark 
environment. Hexane was added to help dissolved the oleylamine-Texas Red mixture. 
The solution of oleylamine-Texas Red NHS ester was then combined with the GMO-
MENs mixture (1:3 volume ratio of GMO-MENs: oleyamine-TexasRed). This mixture 
was then rotated for 12 hours to allow coating. After removal of excess GMO through 
multiple washes in PBS, the final product was store at -20 oC (short-term storage). 
Injection of fMENs in muscles: C57BL6J mice (n = 5) intramuscularly injected with 50 µl 
fMENs (20 mg/ml) at the acupuncture point number 34 Yanglingquan (near the 
depression of anterior and inferior to the head of fibular, on the lateral portion of 
gastrocnemius, part of the peroneus longus, and at the distal end of vastus lateralis). This 
point has been shown to be effectively relieve lower leg pain in human patients and 
animal models (Figure 17) 76, 77. Animal perfusion/ Brain sectioning: Mice were then 
euthanized at 1 hour, 1 day, and 3 days post treatment and muscles was sectioned. In 
brief, mice were deeply anesthetized with (87.3 mg/kg / 13.7 mg/kg) Ketamine/Xylazine 
and perfused transcardially with PBS buffer (0.01 M phosphate saline PBS, 80ml) 
followed by 4% formaldehyde PFA (150 ml) at room temperature. Whole skin-muscle 
group section (gastrocnemius, part of the peroneus longus, and at the distal end of vastus 
lateralis) at the injection area were then dissected and placed in 30% sucrose for 48-72 
hours at 4oC. Tissue preparation and section was done similar to previous report (Meng et 
al. 2014). In brief, tissues were then thoroughly dried with paper towel to remove 
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excessive moisture that could produce freezing artifacts. O.C.T Compound (Sakura 
Finetek, Torrance, CA) was placed in the bottom of a shallow cryomold, enough to 
supply the foundation for oriented muscle. Tissue was oriented with the skin facing the 
OCT base. Once the tissue was placed in the mold with majority of the muscle protruded 
from the OCT so the sectioned muscle of interest is not in contact with OCT. The OCT 
foundation was then freezed with dry ice at ~ -80oC. Isopentane was then used to fill into 
the rest of the mold for fast freezing to prevent muscle fiber degradation during 
sectioning.  The whole solution with muscles and OCT was then fast-freezed with liquid 
nitrogen (~ -140oC to -150oC). Muscle tissues were sectioned at 80 µm thickness with 
cryostat. Tissues were mounted onto glass slides and imaged using using a Neurolucida 
confocal imaging system. 
 
 
Figure 17. Injection of fMENs into a well-established acupuncture point 34 
(Yanglingquan) for treating chronic pain. Yanglingquan acupuncture point exists in a 
depression anterior and inferior to the head of fibula in human (red circle) and its 
corresponding region in rodent (red arrow) 
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Tibial nerved transection injury (TNI) and MENs treatments. TNI injury: 
C57BL6J mice (n = 20 animals / groups) at approximately 30-45 days old were used. For 
injury, the mice were anesthetized with (87.3 mg/kg / 13.7 mg/kg) Ketamine/Xylazine. A 
small incision was made on the left leg to expose the tibial nerve, a silk thread was used 
to make three consecutive loose ligations around it and the nerve was transected distal to 
the ligation. The incision was then sutured and animals were returned to their housing. 
Treatment paradigm: All injured animals were then randomized and divided into four 
groups: Saline treatment, MENs treatment, Saline + magnetic stimulation (ms) treatment, 
MENs + magnetic stimulation (ms) treatment. While animals were under 2% isoflurane, 
50 µl of Saline or MENs-saline (20 mg/ml) were injected into the acupuncture point of 
their respective groups. The leg was then taped to an elevated stage securely between two 
electromagnets. For magnetic stimulation, a 10 Hz continuous magnetic waves of ~850 
Gauss were used. The stimulations were done with duration of 5 minutes interval with 2 
minutes break in between for total of 40 minutes stimulation-time and 10 minutes break-
time. Animals are then subject to behavioral test after stimulation. For 1 day and 3 days 
time-point, animals were only subjected to magnetic stimulation. No further saline or 
MENs injection were done at these two time-points. 
  Von Frey pain behavioral assessment. Mechanical hypersensitivity was 
measured using a mechanical Von Frey anesthesiometer. Calibrated Von Frey filaments 
measuring 100 µm in diameter capable of exerting bending forces of 5, 10, 20, 40 mN 
were applied to the plantar surface of the animal hind paws. Each stimulus lasted 
approximately 1 second and had a 10–15 second intermission between applications. 
Increasing Von Frey filaments were applied until a paw withdrawal was observed and the 
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corresponding stimulation intensity was recorded. Von Frey test was done at multiple 
time points: baseline (before injury), 10 days after injury (to assess pain development), 1 
hour after treatments, 1 day after treatments, and 3 days after treatments. The test was 
done to both ipsilateral hind paw as well as the contralateral hind paw. The test was 
conducted by a research analyst blinded to treatments and group assignment.  
Statistics. Mean values and final plots were developed in Microsoft Excel. All 
statistical analyses were done with, Jmp Analysis 11 (SAS Institute Inc. 2013. Cary, NC), 
and GraphPad Prism 6 (GraphPad Software, La Jolla, California). Two-way ANOVA 
analyses were used for comparing pain response threshold of the treatment groups across 
different time points. For comparisons that yield statistical significance, Tukey’s HSD 




MENs levels in muscle decrease drastically over time after a single injection. 
After injecting fMENs into acupuncture point, repeated confocal imaging of the muscles 
sections that were dissected at various time points were performed to tracked the changes 
in fluorescence intensity in the muscular network. There was high level of fMENs in 
deeper muscular region at 1 hour after injection, which decreased rapidly over 3 days 
(Figure 18A-C). The fluorescence intensity in muscle area dropped to about half after 1 
day and was almost completely abolished at day 3. This suggest that the fMENs 




MENs with magnetic stimulation at acupuncture point resulted significant 
improvement in pain response at the ipsilateral hind paw of tibial nerve injured 
Figure 18. fMENs distribution in muscles decrease significantly 1 day and 3 days after 
treatment. A-C. fMENs fluorescence signals in lateral portion of gastrocnemius muscles right 
at 1 hour after injection (A) and decrease significantly at 1 day (B) and 3 days post treatment 
(C). 
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mice. In order to ensure our injury model resulted in long term pain, we conducted Von 
Frey assessment at baseline and 10 days after injury. There was, in all groups, pre-
treatment, pain response threshold dramatically reduced only in the ipsilateral hind paw 
(Figure 19A). No significant change was observed at the contralateral hind paw (Figure 
19B). This suggests pain has developed in these injured animals. We then treated these 
animals according to their group treatment paradigm. The subsequent MENs-magnetic 
stimulation (ms) significantly increased the threshold of Von Frey test of the ipsilateral 
hind paw almost 3-fold at 1 hour after injection (p > 0.05 compare to control vs. p < 0.01 
of saline group, MENs-only group, and saline-ms group, Two-way ANOVA, Tukey’ 
Figure 19A). The increased threshold was found to be short-lived as it returned to post-
injury level at 1 day and 3 days after treatment (Figure 19A). At the contralateral hind 
paw, there was no changes in pain response at 1 hour and 3 days after treatment, but there 
was a brief increase in pain threshold in the MENs-only and Saline-ms groups (Figure 
19B). This could be due to random chance as there was no change in pain threshold 
observed at this time point for the other remaining two groups: saline-only and MENs-ms 
(Figure 19B). Together, this data suggests MENs treatment combine with magnetic 





 Figure 19. Significant pain relief in MENs magnetic stimulated animals suffered 
from tibial nerve injury (TNI). A. Von Frey assessment of the ipsilateral hind paw 
(injury side) show decreased in mechanical pain threshold of all treatment groups after 
TNI with most dramatic increased in mechanical pain threshold at 1 hour after injury only 
in MENs with magnetic stimulation treatment group (MENs+ms). No change in pain 
threshold in saline-treated, MENs-treated, and saline-magnetic stimulation only groups. 
Two-way ANOVA, Tukey’s HSD, *p < 0.05. B. No change in pain threshold at 
contralateral hind limb of saline, saline+ms and MENs+ms treatment groups with slight 
decrease in pain threshold in MENs-treated group. Increased in pain threshold of 
saline+ms group at 1h post treatment, MENs and saline-ms groups at 1 day, and MENs 




Numerous studies have shown that acupuncture is effective for treating certain 
types of pain, particularly local muscular pain84, 85, 86. This is mainly due to the close 
proximity of acupuncture point in the muscle to the peripheral nerves, an anatomical 
location that is ideal for intercepting pain signals before they reach the brain. Taking 
advantage of this fact, we employed MENs-magnetic stimulation at these acupuncture 
points and found this greatly reduce nociceptive response in tibial nerve injured animal.  
The presence of MENs in the muscles after injection were abundant, however, reduced 
rather quickly in the days following the treatment. This could be due to the nature of 
skeletal muscles, being highly vascularized, which enable the quick clearance of MENs. 
This highly correlated with the observed short-term, but significant, pain relieve in Von 
Frey assessments. More importantly, the effects that were observed are extremely 
promising, it opens a window of possibility in developing pain therapeutics with MENs 
stimulation. Previous study aimed at injecting prostatic acid phosphatase (PAP) into the 
same acupuncture point also shown pain relieve in various mouse models of acute and 
chronic pains83. Mechanistically, this is due to the levels of extracellular adenosine 
monophosphate (AMP) surrounding the peripheral nerve87. Excess extracellular AMP are 
converted to either adenosine triphosphate (ATP) in the synapse to aid with 
neurotransmitter release or back-converted to adenosine. Adenosine then activates 
adenosine 1 receptor (A1R), that resulted in increase in excitatory signal of glutamatergic 
synapses and decrease excitatory signal of gamma (γ)-aminobutyric (GABA)ergic 
synapses at lamina I neuron on the spinal cord88. Thus, injecting PAP at acupuncture 
point manually increase the pool of excess AMP. This enhance in local synaptic activity 
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signals for homeostatic regulation of the signaling pathway all the way up to the motor-
sensory cortex that resulted in reduced nociceptive response83. By injecting MENs 
directly to the acupuncture point and stimulate them with magnet, this directly enhance 
excitatory synaptic response thus direct the homeostatic response back to the proper 
compensation, thus reducing pain. 
Although a promising first step in MENs application in pain treatment, there are 
major drawbacks that needed to be addressed. First, with a single injection, MENs level 
in acupuncture point muscular area dropped greatly with time thus reduce long term 
efficacy of the treatment. This can be addressed by performed injections of MENs at later 
time point before magnetic stimulation, the cumulative effects from multiple injections 
may enhance the pain relief response. Second, to ensure prolong presence of MENs in the 
muscle, even after a single injection, MENs can be conjugated with neural muscular 
junction specific antibodies to MENs. This will direct MENs more specifically towards 
the muscle-nerve interphase and antibody binding will ensure long lasting presence of 
MENs at the area. This is a clear advantage of this MENs approach over traditional 
acupuncture or injecting pharmacological molecules into the acupuncture site. 
Modifications to MENs via conjugations with antibodies or small molecules enable 
diverse modes of delivery that can tremendously improve its therapeutic efficacy. 
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Chapter 6 Conclusions 
In this final chapter, I discuss the novel contributions of this dissertation to the 
field of non-invasive neuromodulation and its implications for a potentially promising 
therapeutic approach to neuropathic pain. Next, I highlight the strengths and weakness of 
the study, and finally, discuss current efforts as well as recommended future directions to 
bring this work eventually to clinical stage.  
Implications for neuromodulation.  
In my dissertation, I set out to explore the potential of magneto-electric 
nanoparticles cobalt ferrite (CoFe2O4) – barium titanate (BaTiO3) in stimulating neuronal 
activity. Specifically, my dissertation focuses on testing its ability to activate neurons 
both in vitro and in vivo, understanding its spatial and temporal distributions once 
introduced into a physiological system, and assessing its toxicity to the brain tissue. 
Finally, I tested MENs stimulatory effects on a neuropathic pain animal model. 
Eventually, I sought answers to these central questions: Do magneto-electric 
nanoparticles (MENs) cobalt ferrite (CoFe2O4) – barium titanate (BaTiO3) stimulation 
enhance neuronal activity (specifically cortical neurons) both in vitro and in vivo? If so, 
what is the spatial and temporal profile of the stimulatory effects? And what type of 
effects do MENs stimulation have, in the context of therapeutic approach, on refractory 
disease animal models, specifically neuropathic pain? 
 This dissertation provided evidence that MENs treatment combining with external 
magnetic application were able to induce and enhance neuronal activity both in vitro and 
in vivo. I, first reported that by using different external magnetic field, we can produce 
vastly different response of the MENs. With strong applied field, MENs can be localized 
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while with weak applied field at specific frequency range could induce electric field 
generation by MENs (Chapter 2). Through calcium imaging, I found MENs stimulation 
can efficiently activate cultured cortical neurons and by modifying the applied magnetic 
field, we were able to improve the neuronal response (Chapter 2). This produced a 
foundation for future subsequence tests in live animals. 
When introduce to a living system, without any magnetic application, MENs was 
found to be circulating for short period of time in the vasculature, thus established the 
critical period for drawing MENs to the brain (Chapter 3). It was then showed MENs can 
be drawn from the blood stream across BBB into the brain with moderately strong 
magnetic field, localized mainly in one cortical hemisphere where magnets were applied, 
and remained at high level for at least 24 hours after delivery (Chapter 3). The presence 
of MENs in the brain tissue resulted in no inflammatory toxicity (i.e. microgliosis or 
astrogliosis) up to one week after treatment (Chapter 3). Through calcium imaging and 
staining for c-Fos protein, MENs stimulatory effects were tested on live animals and 
found by applying weak magnetic field at frequency range between 5 to 20 Hz, MENs 
could efficiently enhance cerebral cortical activity (Chapter 4). Activity enhancement of 
neurons lasted for at least one day and recover within three days after the first treatment 
(Chapter 4). This is highly consistent with the observation of MENs presence in brain 
tissue up to at least one day post injection (Chapter 3). The enhanced activity started 
mostly at the region within the cortical hemisphere where the MENs localized and then 
permeated outward to the surrounding areas (Chapter 4). This is consistent with the one-
hemispherical localization of MENs, after been drawn to the brain (Chapter 3).  
Furthermore, this dissertation also reports the testing of MENs stimulation on a 
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neuropathic pain animal model, tibial nerve transection injury (TNI). After injecting 
MENs intramuscularly into an acupuncture point (well-known for lower muscle pain 
treatment), stimulation of MENs with applied external magnetic field significantly 
increased injured animal nociceptive response threshold (Chapter 5). This relief in pain 
was found to be short term due to MENs level at the treated muscular areas reduced 
greatly over time (Chapter 5). However, these results provide a promising outlook on the 
potential of MENs as a therapeutic approach, not only to pain, but also to other refractory 
neurological diseases. 
Finally, the systematic development of a stimulation protocol, the studies of 
MENs effects in vitro, the spatial and temporal profiles of their presence in living system, 
the spatial and temporal profiles of their effects in vivo, and their promising therapeutic 
potential to neuropathic pain pave the way for future research in applying of particles 
engineering in solving biological problems. While this dissertation emphasizes the 
discovery of the very useful effects of MENs on neuronal activity and its potential 
disease application, further studies in improving its efficacy would greatly solidify its 
role in future trials in humans.  
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Strengths and weaknesses of the dissertation.  
Due to its novel characteristic of exhibiting different magnetic and electric 
properties, depending on the type and strength of magnetic field is applied, a top down 
assessment of its effects was necessary to validate its potential. Comparing with other 
non-invasive neuromodulation techniques, major strengths of MENs are their ability to be 
drawn through BBB and localized to small region of interest and their activity can be 
completely controlled by external magnetic field. A strength of this dissertation comes
from its top-down assessments of not only MENs effects, but also the effects’ spatial and 
temporal profiles as well as its toxicity in living animal. We also tested its effects in 
treating pain. This set the study’s work apart from previous attempts in validating 
nanoparticles roles in neuromodulations31, 33, 48, where their work did not fully test on an 
in vivo system. All of this improved the credibility of our findings.  
 The promising effects of MENs, however, are not without its flaws. First, MENs 
were shown to activate cortical neuronal activity in vivo, but not sufficient to evoke 
downstream motor response, as other techniques such as electrical stimulation, 
transcranial magnetic stimulation, and optogenetics have demonstrated11, 12, 13, 19, 20. 
Second, MENs pain relieving effects were promising but short-term. Our approach 
produces similar pain-relieving effects as other non-invasive brain stimulation techniques 
that were tested to treat pain6, 18, 75, 76, 77, 78, 79, but it is still behind traditional 
pharmacological and surgical approaches5, 6. Future work to improve MENs stimulation 




Current efforts and recommended future directions.  
By the time this dissertation is written, preliminary experiments were conducted 
try to improve the efficacy and the specificity of MENs stimulations.  As mentioned 
before, although MENs stimulation can efficiently enhance cortical neuronal activity, it 
was not sufficient to induce down-stream motor response. This is partially due to the 
required synchronized large population firing of motor cortical neurons in order to evoke 
muscle movements64. Once MENs are drawn to a cortical hemisphere, applied external 
magnetic field facilitated MENs stimulatory effects all neurons in the area. These include 
both excitatory and inhibitory neurons. Furthermore, the act of imaging the calcium 
activity in Thy-1-GCaMP6 expressing neurons only allow for observing activity of 
excitatory synapses. Thus, the enhancement in cortical neuronal activity observed should 
not be expected to produce down-stream motor response due to the possible enhancement 
of inhibitory neuronal activity by MENs that off-set total cortical response.  In order to 
facilitate down-stream evoked motor response, there is a need to further exploit the 
potential of MENs to improve its stimulatory efficacy. Thus, additional effort is being 
made to precisely localize more MENs to a smaller area of the brain, even towards cell-
type specific localization to enable extreme focal neural modulation. 
 One potential solution is to test whether conjugation of antibody to MENs can 
direct the particles to a specific neuronal cell-types. Preliminary, MENs were conjugated 
with an antibody that target the extracellular subunit GluR2 of α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) receptor.  Because AMPA receptors mainly 
express in glutamatergic excitatory neurons, we hypothesize that directing MENs towards 
this cell type should improve its stimulation efficacy towards this cell type. First through 
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histological assessment, the localization of MENs were observed only to extracellular 
membrane of cortical neurons and hippocampal neurons (CA1 area and dentate gyrus) 
when drawn to cortex and hippocampus, respectively (Figure 20A-C). This is highly 
correlate with GluR2 distribution done in mice of similar age in Allen Institute Brain 
database (Allen Brain Atlas).  
 
 
We then tested its effects in vivo by treating animals with MENs-GluR2 
conjugated particles and perform the same calcium imaging experiment as reported in 
Chapter 4. Interestingly, MENs-GluR2 were found to enhance greater neuronal response 
at smaller delay compare to MENs only (Figure 21A-B). The 2 to 3-fold decreased in 
respond latency was not only observed at single cell level but also at populations level as 
well (Figure 22A-B). Even though results are promising, further experiment needs to be 
Figure 20. MENs-GluR2 binds to neurons in both cortex and hippocampus. A-C. 
Representative images of immunofluorescence staining of conjugated MENs-GluR2 to mice 
brain slices show binding of particle-antibody complex to neuronal cell membranes in cortex 
(A), CA1 (B) and dentate gyrus (C) regions of hippocampus. No colocalization of MENs-GluR2 
with DAPI nucleus stains.  
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done to reliably confirmed this improve effects. Furthermore, MENs can also be 
conjugated with neuromuscular junction specific antibody to prolong MENs presence in 
the acupuncture points thus may greatly enhance its pain relief efficacy. 
 
 
 Figure 21. MENs-GluR2 was effective in activating neurons with relatively quicker 
response in vivo. A. Representative two-photon images of calcium signals of cortical layer 
II/III neurons at baseline (MS only) and immediately after MENs-GluR2 delivery followed 
by MS (MEN+MS) and after MS stimluation. 10Hz magnetic stimulation was applied for 
20s in the middle of recording period at each time point. B. Representative traces of 
calcium signals of MENs-GluR2 conjugate treated mouse show shorter response latency 





 Another informative approach to enhance MENs efficacy for brain stimulation is 
to increase MENs crossing through the BBB. As was shown in Chapter 3, once injected 
to the blood, MENs level dissipate within 20 to 30 minutes. Strong magnets used to force 
MENs through BBB may not be sufficient to ensure higher level of MENs in the brain. 
One solution to this is to combine MENs drawing to the brain with ways to either help 
transporting MENs through BBB or open up the BBB for MENs to cross. The transport 
issue can be addressed by conjugating MENs with antibody to target for BBB receptor 
mediated transport proteins such as transferrin, lactoferrin, or low-density lipoprotein
receptor89, 90. The second approach of open up BBB for more MENs penetrations can be 
addressed by combining clinically approved pre-treatment of BBB-opening compounds 
Figure 22. MENs-GluR2 was effective in activating neurons with relatively quicker 
response in vivo observed in both somatic body and population level. A. 
Representative two-photon images of calcium signals of cortical layer II/III neurons at 
baseline (MS only) and immediately after MENs-GluR2 delivery followed by MS 
(MEN+MS) and after MS stimluation. 10Hz magnetic stimulation was applied for 20s in 
the middle of recording period at each time point. B. Representative traces of calcium 
signals of MENs-GluR2 conjugate treated mouse show enhanced response in both 
neuronal soma and large population. 
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such as mannitol91 and borneol92 with MENs localization to increase level of MENs 
crossing BBB towards the central nervous system.  
 In summary, this dissertation demonstrates the ability of magneto-electric 
nanoparticles cobalt ferrite (CoFe2O4) – barium titanate (BaTiO3), to enhance neuronal 
activity efficiently and effectively. By controlling the magnetic field, we can control
both the delivery and activity of MENs in the brain. This also provide promising results 
in therapeutic potential of MENs towards treating neuropathic pain. With many 
drawbacks of current clinical non-invasive brain stimulation techniques, MENs 
stimulation offers a new and improve way to modulate brain activity. Combine with 
diverse ways of nanoparticle modifications, this could potentially open new doors to a 
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RESEARCH EXPERIENCE 
Graduate Research:  
Ph.D. Thesis, “"Magneto-Electric Nanoparticles cobalt ferrite-barium titanate 
(CoFe2O4–BaTiO3) for non-invasive neural modulations." Advisor: Dr. Xiaoming 
Jin, Department of Neurological Surgery & Department of Anatomy and Cell Biology, 
IU School of Medicine, Spinal Cord and Brain Injury Research Group (SCBIRG), Stark 
Neurosciences Research Institute; Clinical advisor: Dr. Richard B. Rodgers, 
Department of Neurological Surgery, Goodman Campbell Brain & Spine Institute, IU 
Health, Indianapolis, IN.  
Particle engineer advisor: Dr. Khizroev Sakhrat, Fellow of National Academy of 
Inventors, Department of Electrical and Computer Engineering, College of Engineering 
and Computing; Department of Cellular Biology and Pharmacology, College of 
Medicine, Florida International University. May 2015 – September 2020 
Thesis Committee members:  Xiaoming Jin Ph.D., Richard B. Rodgers M.D., Armin 
Blesch Ph.D. (co-Chair), Fletcher White Ph.D. (co-Chair), Khizroev Sakhrat Ph.D. 
• Develop a non-invasive stimulation technique using magneto-electric 
nanoparticles (MENs) cobalt ferrite-barium titanate (CoFe2O4–BaTiO3) that is capable of 
both inducing and enhancing cerebral cortical activity with high spatial and temporal 
resolutions, deep penetration, and minimal toxicity, which will potentially be a new 
approach towards treating neural dysfunction in traumatic brain injury (TBI) and spinal 
cord injury (SCI). 
• Characterization of nanoparticle density in brain tissue via electron microscopy 
and confocal microscopy. 
• Assessment of the MENs effect on the integrity of blood brain barrier (BBB) by 
assessing BBB leakage, MENs clearance form blood stream and internal organs, and their 
toxicity to vital organs. 
• Performing in vivo calcium imaging GCaMP-6 mice to determine the effect of 
MENs on activating cortical neurons. 
• Performing mesoscopic whole brain imaging of GCaMP-6 mice to determine the 
global effect of MENs on activating cortical neurons. 
• Performing patch clamp recording and ex-vivo calcium imaging on cortical slices 
to determine MENs effect on neuronal membrane properties, synaptic transmission, and 
dendritic excitability. 
 
• Conjugation of various antibodies to MENs for cell-type specific localizations. 
• Apply MENs stimulation in various TBI models to assess its stimulatory effects in 
treating post-traumatic neural dysfunction and neuropathic pain. 
• Assessing MENs effect on TBI animals via in vivo imaging, electro 
encephalopathy (EEG), electromyography (EMG) recordings, and behavioral tests 
 
M.S. Thesis, “Mechanism of Depressed Responsiveness of motor cortex after mild 
Traumatic Brian Injury (mTBI): Quantitative optogenetic mapping analysis and 
calcium imaging of mice motor cortex dynamics post mTBI.” Advisor: Dr. Xiaoming 
Jin, Department of Neurological Surgery & Department of Anatomy and Cell Biology, 
IU School of Medicine, Spinal Cord and Brain Injury Research Group (SCBIRG), Stark 
Neurosciences Research Institute, May 2014 - May 2016.  
• Investigating the animal functional changes, neurons’ morphological, and 
neuronal plasticity after mTBI 
• Performing cranial preparation for optogenetic EEG recording. 
• Performing craniotomy for optogenetic stimulation and motor cortex mapping  
• Preparing brain slides for investigating the pathological changes using two-photon 
microscopic analysis. 
• Performing optogenetic mapping and electrophysiological recording and analysis 
via electromyography (EMG) and electroencephalography (EEG). 
• Performing Calcium imaging with GCaMP transgenic mice to investigate changes 
of neuronal firing after mTBI via analyzing fluorescence response to investigate 
intracellular calcium dynamics. 
• Performing whole-cell patch clamp recording to investigate ion channel plasticity 
after mTBI by analyzing Evoke Post-Synaptic Current (EPSC). 
• Performing craniotomy to make cranial windows for in vivo calcium imaging. 
• Performing tissue perfusion with to preserve animal brain for morphological 
imaging. 
• Investigating neuronal morphological changes after injury via two-photon 
excitation microscopy. 
• Performing various behavioral testing including: Rotarod test, cylinder test, grid-
walk analysis, and sensory tape test. 
• Investigating the pathological, behavioral, and functional changes in motor cortex 
after two types of spinal cord injuries (unilateral hemisectional injury and bilateral 
pyramidotomy injury) in mice. (Collaboration projects with Dr. Xiaoming Xu, 
Neurosurgery Department, IUSM) 
 
Undergraduate Research: 
 “A stochastic model for bacterial dynamics toward point food sources with 
emergent run-and-tumble.” Advisor: Dr. Steven Presse, Department of Physics 
(IUPUI) & Department of Cellular and Integrative Physiology and Department of 
Medical and Molecular Genetics (adjunct faculty), IU School of Medicine and Advisor: 
Dr. Elliot Rosen, Department of Medical & Molecular Genetic, IU School of Medicine. 
February 2013 – February 2015 
 
• Investigating the predatory dynamics of Bdellovibrio bacteriovorous (B.V) 
towards Escherichia Coli (E.Coli). 
• Grown bacterial culture by suspension and plating.  
• Characterized bacteria with Particle Sizing Technique, Ultraviolet Analysis, and 
Microscopy. 
• Characterized the genetics of Bdellovibrio host dependent and host independent 
strands by Gel Electrophoresis and Polymerase Chain Reaction (PCR). 
• Tracking the bacterial movement by obtaining microscopy (fluorescence and 
confocal) images and using Particle Tracking software. 
• Developing microfluidic chambers for investigating bacterial kinetics towards 
point food source 
• Investigate bacterial hydrodynamic, chemotactic, and electrostatic interaction 
toward different surfaces such as charged/uncharged beads, polar/nonpolar surfaces, and 
high flow environment. 
• Developed an infotaxis kinetic mathematical model to describe B.V dynamics and 
studied B.V motion by simulating model prediction on MathLab and C++. 
• Apply this model to study the various cell type predatory behaviors towards prey 
source. 
 “Synthesis of Di-substituted Chalcones, kinetic study of Hydrogenation reaction, 
and kinetic study of Chalcone-based Lycopene Cyclase inhibitors.” Department of 
Chemistry and Chemical Biology, IUPUI, April 2010- June 2013. Advisor: Dr. Ryan 
Denton 
• Synthesized Non-substituted Chalcones, Mono-substituted Chalcones, and Di-
substituted Chalcones on small scale using heating under reflux as well as a greener 
reaction by solvent free synthesis, and reduced the complexes by Hydrogenation 
reactions with presence of various metals 
• Purified products using various Chromatography techniques, Crystallization. 
• Characterized products with Nuclear Magnetic Resonance (1H NMR), Infrared 
(IR) spectroscopy, Ultra-violet (UV-vis) Spectroscopy, High performance Liquid 
Chromatogrpahy (HPLC), and Gas Chromatography-Mass Spectrometry (GC-MS). 
• Studied hydrogenation rates of each Chalcone’s substituents by model 
discrimination using GC. 
• Studied Chalcone’s reaction properties in form of enzymes in Biological organism 
• Computational research on Lycopene Cyclase and possible Inhibitors for the 
enzyme. 
• Using Swiss-Model for Homology Modeling, Argus Lab and Chimera for 
docking and enzyme kinetics studies. 
• Developing assay for lycopene cyclase with lemons and bell peppers. 
• Synthesized Chalcone-based inhibitors to test on Lycopene cyclase. 
• Implemented part of this research into Organic Chemistry Undergraduate 
Laboratory 
“Kinetic mathematical modeling of reductive hydrogenation of Chalcones 
derivative: 4-Benzyloxy-4-Chloro Chalcones.” Department of Mathematics, IUPUI, 
February 2012 - June 2013. Advisor: Dr. Julia Arciero 
 
• Investigate the kinetic rate of reduction of Multifunctional Chalcones by 
developing a modified Michealis-Menten mathematical model. 
• Utilizing Maple for model building and analysis 
• Utilizing Matlab for model simulation and experimental data fitting. 
 
CURRENT RESEARCH INTERESTS 
• Non-invasive treatment approaches to post-traumatic dysfunction of brain, 
neuropathic pain, and post-traumatic epilepsy (e.g. nanoparticles, focus ultrasonic 
stimulation, etc… 
• Neural plasticity after Spinal Cord (SCI) and Brain (TBI) Injuries, specifically 
reorganization of cortical spinal tract after SCI and changes in glutamate receptors 
function after TBI. 
• Using novel imaging and electrophysiological techniques such as in vivo 
Optogenetic Mapping, in vivo and in vitro calcium imaging, patch-clamp recording to 
study mechanisms of post-traumatic neuronal plasticity. 
• Investigating biological problems using mathematical and physics modeling. 
                 
PUBLICATIONS 
• Tyler Nguyen, Julia Arciero, Joshua Piltz, K. Danielle Hartley, Timothy Rickard, 
Ryan Denton. “Kinetic study of competitive catalytic transfer hydrogenation of a 
multifunctional molecule: 4-benzyloxy-4-chlorochalcone.” Reaction Kinetic, 
Mechanisms and Catalysis. Vol. 109. No. 2. Springer (2013) 
• Hossein Jashnsaz, Tyler Nguyen, Horia I. Petrache, Ph.D, Steve Presse Ph.D. 
“Inferring models of bacterial dynamics toward point sources.” PLOS ONE (2015). 
• Hossein Jashzsaz, Mohammed Al Juboori, Corey Weistuch, Nicholas Miller, 
Tyler Nguyen, Viktoria Meyerhoff, Bryan McCoy, Stephanie Perkins, Ross Wallgren, 
Bruce D. Ray, Konstantinos Tsekouras, Gregory G. Anderson, Steve Presse. 
“Hydrodynamic Hunters” Biophysical Journal. Vol. 112, No. 6: 1282-1289. (2017). 
• Nagesetti, A.; Stewart, T.; Liang, P.; Nguyen, T.; Horstmyer, J.; Khizroev, S. 
“Three-dimensional Navigation of Magnetic Nanoparticle via Enabling metastable 
diamagnetic response.” Human Brain Mapping (2018). 
• Wu, W.; Nguyen, T.; Ordaz, J.; Zhang, Y.; Liu, N.; Hu, X.; Ping, X.; Wu, X.; 
Liu, Y.; Qu, W.; Gao, S.; Shields, C.; Jin, X.; Xu, X. “Activity-mediated rebuilding of an 
alternative corticospinal circuitry in mouse model of Brown-Sequard syndrome.” Nature 
communications (2020) – in revision. 
• Nguyen, T.; Walerstein, J.; Haider Al-Jaboori, M.; Xiong, W.; Jin, X. “Changes 
in ionotropic glutamate receptor functions underlies loss of activities of motor cortex 
after concussive type mild traumatic brain injury (mTBI).” Journal of Neurotrauma 
(2020) – in revision. 
• Nguyen, T.; Gao, J.; Wang, P.; Negessetti A.; Andrews P.; Masood S.; Vriesman 
Z.; Liang P.; Khrizroev S.; Jin X. “Magnetoelectric nanoparticles for magnetic brain 
stimulation with higher spatial and temporal resolutions in vivo.” Nature Methods (2020) 




• CTSI Predoctoral Trainee Award Grant # UL1TR002529 (A. Shekhar, PI), 
5/18/2018 – 4/30/2020. Grant Number UL1TR002529, National Institutes of Health, 
National Center for Advancing Translational Sciences (NIH), Clinical and Translational 
Sciences Award and the Indiana University Department of Medicine.  
• CTSI Predoctoral Trainee Award Grant # TL1TR002531 (A. Shekhar, PI), 
5/18/2020 – 4/30/2021. Grant TL1TR002531, National Institutes of Health, National 
Center for Advancing Translational Sciences (NIH), Clinical and Translational Sciences 
Award and the Indiana University Department of Medicine.  
• IUSM travel awards Fall 2018 (Indiana BioMedical Gateway, IBMG, program)  
• Grant recipient of 2007-2009 Indiana University-Purdue Univeristy Indianapolis 
First Generation Scholarship (FGS) 
• Grant recipient of the Undergraduate Research Opportunity Program (UROP) 
scholarships for “Homology Modeling, Docking, and Biological Assay Development of 
Lycopene Cyclase in Fruit.”. Proposed the development of a crude homology model of 
plant lycopene cyclase, which would be utilized in preliminary docking experiments, 
along with the development of a whole fruit assay to test a series of inhibitors. (August 1, 
2011 – May 30, 2012) 
• IUPUI School of Science Dean’s List 2007-2011 
 
CONFERENCES AND PRESENTATIONS 
• “Multifunctional Chalcone – A competitive reduction studies.” Nguyen, Tyler; 
Iqbal, Tumare; Rickard, Tim; Denton, Ryan. IUPUI Chemistry and Chemical Biology 
Departmental Research Seminar (2010). (Oral Presentation) 
• “Multi-Functional Chalcones Under Reductive Conditions: A Relative Rate 
Study.” Nguyen, Tyler; Rickard, Tim; Hartley, Danielle; Denton, Ryan E. Butler 
Undergraduate Research Conference (2011).  
• “Homology Modeling, Docking, and Biological Assay Development for 
Lycopene Cyclase in Fruit.” Undergraduate Research Program Conference at IUPUI 
(2011). 
• “Catalytic transfer hydrogenation of multi-functional Chalcones with ammonium 
formate.” Nguyen, Tyler; Rickard, Tim; Hartley, Danielle; Iqbal, Tumare; Denton, Ryan. 
42nd Central Regional Meeting of the American Chemical Society, Indianapolis, IN, 
June (2011). 
• “Mathematical modeling on hydrogenations reduction rates of multifunctional 
Chalcones.” Nguyen, Tyler; Piltz, Joshua; Arciero, Julia; Denton, Ryan. Indiana 
University Undergraduate Research Conference (2012) 
• “Tracking Study of Escherichia Coli and Bdellovibrio bacteriovorus towards food 
source using microfluidics.” Nguyen, Tyler; Rosen, Elliot; Johnsons, Merrell; Petrache, 
Horia; and Presse, Steven. 2014 Indiana Academy of Science Midwest Symposium. 
(March 2014). (Oral Presentation) 
• “A model for bacteria decision making based on stochastic event detection.” 
Nguyen, Tyler; Jashnsaz, Hossein; Presse, Steven. 2014 Indiana Academy of Science 
Midwest Symposium. (March 2014). 
• “Identifying the role of hydrodynamic interaction son predation of the predation 
of Bdellovibrio bacteriovorus.” Nguyen, Tyler; Jashnsaz, Hossein; Al Juboori, 
 
Mohammad; Miller, Nick; Anderson, Gregory; Presse, Steven. IUPUI Nanotechnology 
Research Forum and Poster Symposium. (2015).  
• “Optogenetic mapping revealed longitudinal changes in mouse motor cortex after 
closed-head mild Traumatic Brain Injury (mTBI).” Nguyen, Tyler; Jin, Xiaoming. 
Indiana University School of Medicine Spinal Cord and Brain Injury Research seminar 
(November 2014). (Oral presentation) 
• “Optogenetic mapping revealed longitudinal changes in cortical motor map 
following closed-head mild traumatic brain injury (mTBI)” Nguyen, Tyler; Ping, 
Xingjie; Jin, Xiaoming. Kentucky Spinal Cord and Brain Trauma Midwest Symposium. 
Louisville, Kentucky. (Jun 2015) 
• “Mechanism of mild Traumatic Brain Injury (mTBI).” Nguyen, Tyler. Indiana 
University School of Medicine Spinal Cord and Brain Injury Research seminar 
(September 2015). (Oral presentation) 
• “Transcranial optogenetic mapping revealed longitudinal changes in motor maps 
of ipsi-lesional and contra-lesional cortex following mild traumatic brain injury.” 
Nguyen, Tyler; Jin, Xiaoming. Society for Neuroscience 2015 National Conference. 
Chicago, Illinois. (Oct 2015) 
• “Changes in Glutamate receptor functions following mild Traumatic Brain Injury 
(mTBI)” Nguyen, Tyler. 2nd Signature Center Initiative Symposium for Indiana Spinal 
Cord and Brain Injury Research. Indianapolis, Indiana. (Oct 2016), (Oral Presentation) 
• “Magneto-electric nanoparticle for non-invasive brain stimulation.” Nguyen, 
Tyler; Vriesman, Zoe; Stewart, Tiffanie; Khizroev, Sakhrat; Jin, Xiaoming. 2017 Jack & 
Linda Gill Symposium & Awards. Indiana University. Bloomington, Indiana. (Sep 2017), 
(Poster presentation). 
• “Activation of cortical neuron by magneto-electric colbalt-ferrite barium titanate 
nanoparticle based non-invasive brain stimulations.” Nguyen, Tyler. Indiana University 
School of Medicine Spinal Cord and Brain Injury Research seminar (October 2017). 
(Oral presentation) 
• “Colbalt-Ferrite Barium Titanate nanoparticles for brain stimulation.” Nguyen, 
Tyler. Stark Neuroscience Research Seminar (Feburary 2018). (Oral presentation) 
• “Magneto-electric nanoparticle activates cortical neuronal cell in vitro.” Nguyen, 
Tyler. Indiana University/Purdue University Brain and Spinal Cord injury symposium 
(September 2018). (Poster Presentation). 
• “Magneto-electric nanoparticle for non-invasive brain stimulation, an in vivo 
study.” Nguyen, Tyler; Vriesman, Zoe; Andrews, Peter; Masood, Sehban; Stewart, 
Tiffanie; Khizroev, Sakhrat; Jin, Xiaoming. 2018 Jack & Linda Gill Symposium & 
Awards. Indiana University. Bloomington, Indiana. (Sep 2018), (Poster presentation). 
• “Non-invasive neuronal activation by magneto-electric nanoparticles.” Nguyen, 
Tyler; Vriesman, Zoe; Andrews, Peter; Masood, Sehban; Stewart, Tiffanie; Khizroev, 
Sakhrat; Jin, Xiaoming. 2019 Greater Indiana Society for Neuroscience. IUPUI. 
Indianapolis, Indiana. (March 2019). (Poster presentation). 
• “Effects of magneto electric nanoparticle stimulation on neuronal activity, an in 
vitro study.” Nguyen, Tyler. 2019 Stark Neuroscience summer symposium. (July 2019), 
(Oral presentation). 
• “Magneto-electric nanoparticles for non-invasive brain stimulation, in vivo mouse 
imaging study.” Nguyen, Tyler; Vriesman; Zoe, Andrew, Peter; Masood, Sehban; 
 
Sakhrat, Khizroev; Jin, Xiaoming. 2019 Indiana CTSI Annual Meeting. (September 
2019), (Poster Presentation). 
• “Cobalt Ferrite-Barium titanate magnetic electric nanoparticles, a new frontier in 
neuromodulation.” Nguyen, Tyler; Andrew, Peter; Sakhrat Khizroev; Jin, Xiaoming. 
2019 Gill Symposium & Awards. (September 2019), (Poster Presentation). 
• “Effects and Mechanism of cobalt ferrite-barium titanate nanoparticles non-
invasive neural modulation.” Nguyen, Tyler; Vriesman; Zoe, Andrew, Peter; Masood, 
Sehban; Stewart, Tiffanie; Nagasetti, Abhinegan; Sakhrat, Khizroev; Jin, Xiaoming. 2019 
Society for Neuroscience meeting (SfN). (October 2019), (Poster Presentation). 
• “Non-invasive neuromodulations, history & current frontiers.” Tyler, Nguyen. 
Indiana Spinal Cord and Brain Injury Fall Seminar Series. (November 2019), (Oral 
Presentation). 
• “Magneto-Electric nanoparticle – the next frontier in neural modulation.” Tyler, 
Nguyen. Association for clinical and translational science (ACTS) conference. 
Washington D.C (April 2020), (Oral Presentation) 
 
TEACHING EXPERIENCE 
Teaching Assistance, General Chemistry (C125), IUPUI, May 2012- June 2015 
• Lecture over General Chemical theories, Chemistry Lab techniques, and 
conduction reactions. 
• Instruct students on how to carry out a chemical reaction, isolate, purify, and 
analyze the reaction products. 
Teaching Assistance, Organic Chemistry Laboratory II (C344), IUPUI, August 2011- 
May 2013 
• Lecture over Organic Chemistry Reactions, theories, and Instrumental techniques. 
• Instruct students on how to carry out organic chemistry experiment. 
• Analyzed students’ experimental products with various analytical instruments 
(Infrared Spectrometer, Gas Chromatography and Liquid Chromatography, Mass 
Spectrometer, H-NMR). 
Laboratory instructor, Instrumental Analytical Chemistry (C411), IUPUI, August 2013 – 
December 2013 
• Lecture over concepts, design, and functions of different analytical Instruments 
(such as Flame Ionizations, Gas and Liquid chromatography, Mass spectrometry, Fourier 
Transform Infrared Spectroscopy, Ultraviolet Spectroscopy). 
• Instruct students on how to develop methods, run, trouble shoot, and maintain 
different instruments. 
• Instruct students on how to choose the appropriate instrument(s) to analyze a 
sample of interest. 
Laboratory instructor, Experimental Physical Chemistry of Bulk Matter (C363), IUPUI, 
January 2014 – May 2014  
• Lecture over concepts, design, and functions of different physical chemistry 
related analytical instruments (such as Bomb Calorimeter, Magnetic susceptibility 
analysis, Viscometer, Tensiometer, C-NMR, IR, and Gas Chromatography) 
• Instruct students on how to develop methods, run the instruments, and analyze 
data 
 
• Instruct students on how to design experiments that utilize combinations of 




• Business Developer, the Change for Change campaign and the Change for 
Change Benefit event, project manager: Mr. Aaron Christian at IUPUI, January 2010 – 
May 2010. 
• Conducted Powerpoint presentation to local and national businesses to encourage 
for donations for the campaign and sponsorship of the event. 
• Organizing the Change for Change Benefit event that resulted in over 5000 
dollars donation to the Freedom Writer Foundation 
Chemistry tutor at IUPUI Chemistry Resource Center (2012-2014) 
Volunteer, IU Health University Hospital Dialysis Outpatient Center 2007-2010 
COMPUTER EXPERIENCE 
• Proficient in Excel, MS word, Powerpoint, Apple Numbers, Pages, and Keynote 
• Scientific modeling analysis:  SciFinder Scholar, ChemDraw, Cambridge 
Structural 
Database, Time Series Analyzer software (Calcium imaging), and OriginPro Lab Imaging 
(optogenetic mapping) 
• Homology Modeling and Biochemical analysis: Swiss-Model, Spartan, Argus 
Lab, and Chimera 
• Programming languages for mathematical modelling: Python, C++, and Matlab 
Statistical analysis: Jmp, Prism, and StatPlus (Mac OS) 
• Electrophysiological data recording via pClamp Software for EMG and EEG, 
Metamorph Microscopy software for calcium imaging, and electrophysiological data 
analysis via Detector® software 
 
CONTRIBUTION TO SCIENCE 
• Early Career: My early career contributions were focused on two set of works: 
(a) Investigating the reduction reaction kinetics of a di-substituted chalcones-type 
molecules called 4-Benzyloxy-4-Chloro Chalcones. This molecule is of particular 
importance due to its natural existence in orange and yellow fruits and vegetables and has 
been shown to be an effective treatment in reducing prostate and ovarian cancer cysts. 
Within the plants, lycopene cyclase enzyme converts this chalcones into beta-carotenes 
that gives rise to the bright orange and yellow color of the fruits. By understanding the 
kinetics of this reaction, one can minimize the reduction and extract chalcones from the 
plants. I performed various types of reduction reaction of this multifunctional chalcones 
and use various spectroscopic technique to investigates the resulting products and the rate 
in which each product formed. I also, in collaboration with an applied mathematician, 
developed a kinetic mathematical model, derived from Laws of Mass Actions, to help 
predict the rate of products formations when given various types of function groups. (b) 
Investigate the predatory dynamics of Bdellovibrio bacteriovorous (B.V.) towards 
Escherichia Coli (E.Coli) and develop a stochastic mathematical model to predict the 
 
searching behavior of a predator towards its prey, taken into account combinations of 
environmental factors such as chemotaxis, barotaxis, thimotaxis, and the subject’s 
Poisson random movements. This model is able to not only predict movement behavior 
but also is the foundation of building an algorithm, in which, one can control an object 
movement based on information collected from surrounding before the movement is 
decided. I also developed the culturing protocol of B.V. and E.Coli and designed a 
“hunting chamber” using microfluidics to assess the predatory behavioral of B.V. in real-
time. This helped tested the model predictions. 
• Graduate Career: My graduate work focuses on set of directions: (a) Investigate 
the neural plasticity of the motorsensory cortices after traumatic brain injury (TBI) and 
spinal cord injury (SCI). For TBI, I utilized various electrophysiological, functional 
imaging, and behavioral assessment techniques: optogenetic mapping, calcium imaging, 
field potential recording, glutamate uncaging with two-photon imaging to investigate the 
change in activity of the sensory-motor pathway at both the systemic level and cellular 
level. I then assess the molecular mechanism, in which glutamatergic ion channel 
dysfunction gives rise to cellular and behavioral deficits after trauma. For SCI, I utilized 
optogenetic stimulation and optogenetic mapping to investigate the reorganization of the 
corticospinal tract (CST). I also showed, as proof-of-concept, that stimulation of the 
motor cortex induces CST reorganization in such a way that improved behavioral 
outcomes were observed. (b) The later part of my graduate work focused on developing a 
new and improve non-invasive brain stimulation technique using magnetic-electric 
nanoparticles (MENs) cobalt ferrite-barium titanate (CoFe2O4–BaTiO3). By applying 
various functional imaging techniques, I demonstrated both in vitro and in vivo that 
MENs can be safely used to modulate neuronal activity. My research has shown MENs 
can be: injected into the blood stream intravenously, safely and wirelessly guided through 
the blood and cross the blood brain barrier to localize in a small brain region. A weak 
magnetic field can then be used to activate MENs in the brain and enhance neuronal 
activity. I then showed MENs stimulation is effective in reducing nociceptive responses 
in tibial  
• Postdoctoral Career: As a postdoctoral fellow, my research will be focused on 
investigating the role of neuroinflammation in contributing to the pathology and 
behavioral deficits, particularly pain, after traumatic brain injury and ultimately long-term 
neurodegenerations. 
 
